<html lang="en" dir="ltr" xmlns="http://www.w3.org/1999/xhtml" xmlns:mml="http://www.w3.org/1998/Math/MathML">
 <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#">
  <link rel="dns-prefetch" href="//d33xdlntwy0kbs.cloudfront.net"/>
  <link rel="dns-prefetch" href="//www.google.com"/>
  <link rel="dns-prefetch" href="//scholar.google.com"/>
  <link rel="dns-prefetch" href="//www.google-analytics.com"/>
  <link rel="dns-prefetch" href="//stats.g.doubleclick.net"/>
  <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
  <meta name="viewport" content="width=device-width, initial-scale=1"/>
  <link rel="shortcut icon" href="https://www.medrxiv.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon"/>
  <link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/10.1101/2020.11.13.20231332v3.full.pdf"/>
  <link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/10.1101/2020.11.13.20231332v3.full.txt"/>
  <link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/10.1101/2020.11.13.20231332v3.ppt"/>
  <meta name="article_thumbnail" content="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-1.gif"/>
  <meta name="type" content="article"/>
  <meta name="category" content="article"/>
  <meta name="HW.identifier" content="/medrxiv/early/2022/09/30/2020.11.13.20231332.atom"/>
  <meta name="HW.pisa" content="medrxiv;2020.11.13.20231332v3"/>
  <meta name="DC.Format" content="text/html"/>
  <meta name="DC.Language" content="en"/>
  <meta name="DC.Title" content="Multi-state network meta-analysis of cause-specific survival data"/>
  <meta name="DC.Identifier" content="10.1101/2020.11.13.20231332"/>
  <meta name="DC.Date" content="2022-09-30"/>
  <meta name="DC.Publisher" content="Cold Spring Harbor Laboratory Press"/>
  <meta name="DC.Rights" content="© 2022, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission."/>
  <meta name="DC.AccessRights" content="restricted"/>
  <meta name="DC.Description" content="Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta-analysis to estimate relative treatment effects between all interventions in the evidence base. Often there is an interest in estimating the relative treatment effects regarding time-to-event outcomes. Cancer treatment effectiveness is frequently quantified by analyzing overall survival (OS) and progression-free survival (PFS). In this paper we introduce a method for the joint network meta-analysis of PFS and OS that is based on a time-inhomogeneous tri-state (stable, progression, and death) Markov model where time-varying transition rates and relative treatment effects are modeled with known parametric survival functions or fractional polynomials. The data needed to run these analyses can be extracted directly from published survival curves. We demonstrate use by applying the methodology to a network of trials for the treatment of non-small-cell lung cancer. The proposed approach allows the joint synthesis of OS and PFS, relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost-effectiveness analyses.

### Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at [www.icmje.org/coi\_disclosure.pdf][1] and declare: no financial support from any organisation for the submitted work; All authors have completed the ICMJE uniform disclosure form at [www.icmje.org/coi\_disclosure.pdf][1] and declare: no financial support from any organisation for the submitted work; JPJ, DI, and TT have nothing to disclose related to this work.

### Funding Statement

This work was supported by the UCSF Academic Senate Committee on Research (Academic Senate RAP Grant). The funders had no role in the preparation, review, or approval of the manuscript or the decision to submit the manuscript for publication. 

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Dataset is available upon reasonable request.

 [1]: http://www.icmje.org/coi\_disclosure.pdf"/>
  <meta name="DC.Contributor" content="Jeroen P. Jansen"/>
  <meta name="DC.Contributor" content="Devin Incerti"/>
  <meta name="DC.Contributor" content="Thomas A. Trikalinos"/>
  <meta name="article:published_time" content="2022-09-30"/>
  <meta name="citation_title" content="Multi-state network meta-analysis of cause-specific survival data"/>
  <meta name="citation_abstract" lang="en" content="<h3>Abstract</h3>
<p>Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta-analysis to estimate relative treatment effects between all interventions in the evidence base. Often there is an interest in estimating the relative treatment effects regarding time-to-event outcomes. Cancer treatment effectiveness is frequently quantified by analyzing overall survival (OS) and progression-free survival (PFS). In this paper we introduce a method for the joint network meta-analysis of PFS and OS that is based on a time-inhomogeneous tri-state (stable, progression, and death) Markov model where time-varying transition rates and relative treatment effects are modeled with known parametric survival functions or fractional polynomials. The data needed to run these analyses can be extracted directly from published survival curves. We demonstrate use by applying the methodology to a network of trials for the treatment of non-small-cell lung cancer. The proposed approach allows the joint synthesis of OS and PFS, relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost-effectiveness analyses.</p>"/>
  <meta name="citation_journal_title" content="medRxiv"/>
  <meta name="citation_publisher" content="Cold Spring Harbor Laboratory Press"/>
  <meta name="citation_publication_date" content="2022/01/01"/>
  <meta name="citation_mjid" content="medrxiv;2020.11.13.20231332v3"/>
  <meta name="citation_id" content="2020.11.13.20231332v3"/>
  <meta name="citation_public_url" content="https://www.medrxiv.org/content/10.1101/2020.11.13.20231332v3"/>
  <meta name="citation_abstract_html_url" content="https://www.medrxiv.org/content/10.1101/2020.11.13.20231332v3.abstract"/>
  <meta name="citation_full_html_url" content="https://www.medrxiv.org/content/10.1101/2020.11.13.20231332v3.full"/>
  <meta name="citation_pdf_url" content="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332.full.pdf"/>
  <meta name="citation_doi" content="10.1101/2020.11.13.20231332"/>
  <meta name="citation_num_pages" content="57"/>
  <meta name="citation_article_type" content="Article"/>
  <meta name="citation_firstpage" content="2020.11.13.20231332"/>
  <meta name="citation_author" content="Jeroen P. Jansen"/>
  <meta name="citation_author_institution" content="Dept. Clinical Pharmacy, School of Pharmacy, University of California - San Francisco"/>
  <meta name="citation_author_institution" content="Precision HEOR"/>
  <meta name="citation_author_email" content="jeroen.jansen@ucsf.edu"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0003-2686-9217"/>
  <meta name="citation_author" content="Devin Incerti"/>
  <meta name="citation_author_institution" content="Previously at Precision HEOR"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-4479-8750"/>
  <meta name="citation_author" content="Thomas A. Trikalinos"/>
  <meta name="citation_author_institution" content="Departments of Health Services, Policy and Practice and of Biostatistics and Center for Evidence Synthesis in Health, Brown University School of Public Health"/>
  <meta name="citation_author_orcid" content="http://orcid.org/0000-0002-3990-1848"/>
  <meta name="citation_reference" content="Dias S, Ades AE, Welton NJ, Jansen JP, Sutton AJ. Generalised linear models in Network meta-analysis for decision-making:93-153John Wiley & Sons, Ltd 2018."/>
  <meta name="citation_reference" content="West H Dahlberg S. Clinical Trials, End Points, and Statistics â Measuring and Comparing Cancer Treatments in Practice JAMA Oncology. 2018 ;4:1798."/>
  <meta name="citation_reference" content="Dias S, Ades AE, Welton NJ, Jansen JP, Sutton AJ. Network meta-analysis of survival outcomes in Network meta-analysis for decision-making:293-322John Wiley & Sons, Ltd 2018."/>
  <meta name="citation_reference" content="Ouwens MJNM, Philips Z, Jansen JP. Network meta-analysis of parametric survival curves Research Synthesis Methods. 2010;1:258–271."/>
  <meta name="citation_reference" content="Jansen JP. Network meta-analysis of survival data with fractional polynomials BMC Medical Research Methodology. 2011;11:1–14."/>
  <meta name="citation_reference" content="Jansen JP, Cope S. Meta-regression models to address heterogeneity and inconsistency in net-work meta-analysis of survival outcomes BMC Medical Research Methodology. 2012;12:1–16."/>
  <meta name="citation_reference" content="Cope S, Chan K, Jansen JP. Multivariate network meta-analysis of survival function parameters Research Synthesis Methods. 2020;11:443–456."/>
  <meta name="citation_reference" content="Woods B, Sideris E, Palmer S, Latimer N, Soares M. NICE DSU technical support document 19. Partitioned survival analysis for decision modelling in health care: a critical review. 2017 Available from: www.nicedsu.org.uk/wp-content/uploads/2017/06/Partitioned-Survival-Analysisfinal-report.pdf. 2018."/>
  <meta name="citation_reference" content="Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models Statistics in Medicine. 2007;26:2389–2430."/>
  <meta name="citation_reference" content="Guyot P, Ades AE, Ouwens MJNM, Welton NJ. Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves BMC Medical Research Methodology. 2012;12:1–13."/>
  <meta name="citation_reference" content="Welton NJ, Ades AE. Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration Medical Decision Making. 2005;25:633–645."/>
  <meta name="citation_reference" content="Price MJ, Welton NJ, Ades AE. Parameterization of treatment effects for meta-analysis in multi-state Markov models Statistics in Medicine. 2011;30:140–151."/>
  <meta name="citation_reference" content="Ades AE, Mavranezouli I, Dias S, Welton NJ, Whittington C, Kendall T. Network meta-analysis with competing risk outcomes Value in Health. 2010;13:976–983."/>
  <meta name="citation_reference" content="Cooper NJ, Sutton AJ, Morris D, Ades AE, Welton NJ. Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation Statistics in Medicine. 2009;28:1861–1881."/>
  <meta name="citation_reference" content="Wu Ylong, Cheng Y, Zhou X, et al. Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial The Lancet Oncology. 2017;18:1454–1466."/>
  <meta name="citation_reference" content="Mok TS, Cheng Y, Zhou X, et al. Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations Journal of Clinical Oncology. 2018:JCO–2018."/>
  <meta name="citation_reference" content="Park K, Tan E-H, O’Byrne K, et al. Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, openlabel, randomised controlled trial The Lancet Oncology. 2016;17:577–589."/>
  <meta name="citation_reference" content="Paz-Ares L, Tan E-H, O’byrne K, et al. Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial Annals of Oncology. 2017;28:270–277."/>
  <meta name="citation_reference" content="Sequist LV, Yang JC-H, Yamamoto N, et al. Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations Journal of Clinical Oncology. 2013;31:3327–3334."/>
  <meta name="citation_reference" content="Yang JC-H, Wu Y-L, Schuler M, et al. Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials The Lancet Oncology. 2015;16:141–151."/>
  <meta name="citation_reference" content="Wu Y-L, Zhou C, Hu C-P, et al. Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial The Lancet Oncology. 2014;15:213–222."/>
  <meta name="citation_reference" content="Costa C, Molina-Vila MA, Drozdowskyj A, et al. The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial Clinical Cancer Research. 2014:clincanres–2233."/>
  <meta name="citation_reference" content="De Marinis F, Vergnenegre A, Passaro A, et al. Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial Future Oncology. 2015;11:421–429."/>
  <meta name="citation_reference" content="Rosell R, Carcereny E, Gervais R, et al. Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial The Lancet Oncology. 2012;13:239–246."/>
  <meta name="citation_reference" content="Wu Y-L, Zhou C, Liam C-K, et al. First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study Annals of Oncology. 2015;26:1883–1889."/>
  <meta name="citation_reference" content="Zhou C, Wu Y-L, Chen G, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study The Lancet Oncology. 2011;12:735–742."/>
  <meta name="citation_reference" content="Zhou C, Wu YL, Chen G, et al. Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802) Annals of Oncology. 2015;26:1877–1883."/>
  <meta name="citation_reference" content="Han J-Y, Park K, Kim S-W, et al. First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung Journal of Clinical Oncology. 2012;30:1122–1128."/>
  <meta name="citation_reference" content="Mitsudomi T, Morita S, Yatabe Y, et al. Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial The Lancet Oncology. 2010;11:121–128."/>
  <meta name="citation_reference" content="Fukuoka M, Wu Y-L, Thongprasert S, et al. Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non–small-cell lung cancer in Asia (IPASS) Journal of Clinical Oncology. 2011;29:2866–2874."/>
  <meta name="citation_reference" content="Mok TS, Wu Y-L, Thongprasert S, et al. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma New England Journal of Medicine. 2009;361:947–957."/>
  <meta name="citation_reference" content="Inoue A, Kobayashi K, Maemondo M, et al. Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Annals of Oncology. 2012;24:54–59."/>
  <meta name="citation_reference" content="Maemondo M, Inoue A, Kobayashi K, et al. Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR New England Journal of Medicine. 2010;362:2380–2388."/>
  <meta name="citation_reference" content="Han B, Jin B, Chu T, et al. Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial International Journal of Cancer. 2017;141:1249–1256."/>
  <meta name="citation_reference" content="Yang JC-H, Kang JH, Mok T, et al. First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: a randomised, phase 3 trial European Journal of Cancer. 2014;50:2219–2230."/>
  <meta name="citation_reference" content="Yang JC-H, Srimuninnimit V, Ahn M-J, et al. First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 Study Journal of Thoracic Oncology. 2016;11:370–379."/>
  <meta name="citation_reference" content="Plummer M. JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling 2003."/>
  <meta name="citation_reference" content="R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2013 2014."/>
  <meta name="citation_reference" content="Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit Journal of the Royal Statistical Society: Series b (Statistical Methodology). 2002;64:583–639."/>
  <meta name="citation_reference" content="Dias S, Ades AE, Welton NJ, Jansen JP, Sutton AJ. Network Meta-analysis within costeffectiveness analysis in Network meta-analysis for decision-making:155-178John Wiley & Sons, Ltd 2018."/>
  <meta name="twitter:title" content="Multi-state network meta-analysis of cause-specific survival data"/>
  <meta name="twitter:site" content="@medrxivpreprint"/>
  <meta name="twitter:card" content="summary"/>
  <meta name="twitter:image" content="https://www.medrxiv.org/sites/default/files/images/medrxiv_logo_homepage7-5-small-test-up.png"/>
  <meta name="twitter:description" content="Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta-analysis to estimate relative treatment effects between all interventions in the evidence base. Often there is an interest in estimating the relative treatment effects regarding time-to-event outcomes. Cancer treatment effectiveness is frequently quantified by analyzing overall survival (OS) and progression-free survival (PFS). In this paper we introduce a method for the joint network meta-analysis of PFS and OS that is based on a time-inhomogeneous tri-state (stable, progression, and death) Markov model where time-varying transition rates and relative treatment effects are modeled with known parametric survival functions or fractional polynomials. The data needed to run these analyses can be extracted directly from published survival curves. We demonstrate use by applying the methodology to a network of trials for the treatment of non-small-cell lung cancer. The proposed approach allows the joint synthesis of OS and PFS, relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost-effectiveness analyses.

### Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at [www.icmje.org/coi\_disclosure.pdf][1] and declare: no financial support from any organisation for the submitted work; All authors have completed the ICMJE uniform disclosure form at [www.icmje.org/coi\_disclosure.pdf][1] and declare: no financial support from any organisation for the submitted work; JPJ, DI, and TT have nothing to disclose related to this work.

### Funding Statement

This work was supported by the UCSF Academic Senate Committee on Research (Academic Senate RAP Grant). The funders had no role in the preparation, review, or approval of the manuscript or the decision to submit the manuscript for publication. 

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Dataset is available upon reasonable request.

 [1]: http://www.icmje.org/coi\_disclosure.pdf"/>
  <meta name="og-title" property="og:title" content="Multi-state network meta-analysis of cause-specific survival data"/>
  <meta name="og-url" property="og:url" content="https://www.medrxiv.org/content/10.1101/2020.11.13.20231332v3"/>
  <meta name="og-site-name" property="og:site_name" content="medRxiv"/>
  <meta name="og-description" property="og:description" content="Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta-analysis to estimate relative treatment effects between all interventions in the evidence base. Often there is an interest in estimating the relative treatment effects regarding time-to-event outcomes. Cancer treatment effectiveness is frequently quantified by analyzing overall survival (OS) and progression-free survival (PFS). In this paper we introduce a method for the joint network meta-analysis of PFS and OS that is based on a time-inhomogeneous tri-state (stable, progression, and death) Markov model where time-varying transition rates and relative treatment effects are modeled with known parametric survival functions or fractional polynomials. The data needed to run these analyses can be extracted directly from published survival curves. We demonstrate use by applying the methodology to a network of trials for the treatment of non-small-cell lung cancer. The proposed approach allows the joint synthesis of OS and PFS, relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost-effectiveness analyses.

### Competing Interest Statement

All authors have completed the ICMJE uniform disclosure form at [www.icmje.org/coi\_disclosure.pdf][1] and declare: no financial support from any organisation for the submitted work; All authors have completed the ICMJE uniform disclosure form at [www.icmje.org/coi\_disclosure.pdf][1] and declare: no financial support from any organisation for the submitted work; JPJ, DI, and TT have nothing to disclose related to this work.

### Funding Statement

This work was supported by the UCSF Academic Senate Committee on Research (Academic Senate RAP Grant). The funders had no role in the preparation, review, or approval of the manuscript or the decision to submit the manuscript for publication. 

### Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Dataset is available upon reasonable request.

 [1]: http://www.icmje.org/coi\_disclosure.pdf"/>
  <meta name="og-type" property="og:type" content="article"/>
  <meta name="og-image" property="og:image" content="https://www.medrxiv.org/sites/default/files/images/medrxiv_logo_homepage7-5-small-test-up.png"/>
  <meta name="citation_date" content="2022-09-30"/>
  <meta name="description" content="medRxiv - The Preprint Server for Health Sciences"/>
  <meta name="generator" content="Drupal 7 (http://drupal.org)"/>
  <link rel="canonical" href="https://www.medrxiv.org/content/10.1101/2020.11.13.20231332v3"/>
  <link rel="shortlink" href="https://www.medrxiv.org/node/565946"/>
  <title>
   Multi-state network meta-analysis of cause-specific survival data | medRxiv
  </title>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__7SC0i-kTgUlQGKuqbmyS18Sez8FDO-aG9FSHkGrLGl8__9Xf-fJpmF9h8tvWywQTaOzJzFLt4sEfx108Wh1gYmm0__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__JbFqFjYGp4Zx8gvmj6v5YmfNmbiFphGHPblyC9bfG5Y__OScmsb_1nSVmm_Ax3cJ5Rq7p081PahYkvF_YWQd5GtE__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <style type="text/css" media="all">
   /* &lt;![CDATA[ */
.panels-flexible-new .panels-flexible-region{padding:0}.panels-flexible-new .panels-flexible-region-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-region-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-region-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-column{padding:0}.panels-flexible-new .panels-flexible-column-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-new .panels-flexible-column-inside-first{padding-left:0}.panels-flexible-new .panels-flexible-column-inside-last{padding-right:0}.panels-flexible-new .panels-flexible-row{padding:0 0 .5em;margin:0}.panels-flexible-new .panels-flexible-row-last{padding-bottom:0}.panels-flexible-column-new-main{float:left;width:99.0000%}.panels-flexible-new-inside{padding-right:0}.panels-flexible-new{width:auto}.panels-flexible-region-new-center{float:left;width:99.0000%}.panels-flexible-row-new-main-row-inside{padding-right:0}
/* ]]&gt; */
  </style>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__PWuQ_RYRTJ4BLEKsbWQeHysPg0gOQ3571ruQa_rXvAo__cj81oxtSGUe-AIO3tlkSBJPNpKP5ZgLdB8f8awBQsWU__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <style type="text/css" media="all">
   /* &lt;![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:gray}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]&gt; */
  </style>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__Wnlyen9qEpwh_Qaf9okEu4QdVGM0BDothxeqA6Nbvo8__EJmw6SZD9bYoS8jocCpPYS3JFRURpdzmuvJoAUNiI-g__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__MF4P_i8lKWP7DQR7GmjDAVTRBKLnzxvs1Dvton-Awi0__yi5OflfckG_G8-Li4dDQQ3wO9cGIcdPx_YQ7ZZDuj5w__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://www.medrxiv.org/sites/default/files/advagg_css/css__5mxrBK4DuyvC2MR5irx_TzVn9c8vr4vIjmBXjunHfxE__rtQnXv8GOc-AsynbhzSlQBD_2lVxAkB6XEFUCK72qXc__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.css" media="all"/>
  <link type="text/css" rel="stylesheet" href="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.css" media="all"/>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BKYqkKToQ7EjirB7eIdMEH5521EU3da9IpoOs8Ex2XI__aSjVoX8giBmLhN2EbCgIGQJNu89Mh5aVu1LvI_gkJ7Y__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__4Cn2dxvNlsJ-sHe6QOTLREaQvcqb0Yh0Zm9tTOHtQow__JeZEUjzbaj_yX6UjCI8eBbXy_J64ZVuoWmc2fSpLZHo__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="https://www.google.com/recaptcha/api.js?hl=en&render=explicit&onload=drupalRecaptchaOnload">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__dGWpV57YWu3sX6UOe04RMH-iP9jSkEP7Ajt0caYXZZk__u2clNMaOO3LCM0tpFNpsQhnHrJ4_SUXG1gFb00eB1iU__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js">
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&amp;&amp;g(l.readyState)&amp;&amp;(u.r=o=1,!q&amp;&amp;h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&amp;&amp;m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&amp;&amp;y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&amp;&amp;(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&amp;&amp;(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&amp;&amp;h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&amp;&amp;!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&amp;&amp;"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&amp;&amp;!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&amp;&amp;(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f&lt;d;f++)g=a[f].split("="),(e=z[g.shift()])&amp;&amp;(c=e(c,g));for(f=0;f&lt;b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&amp;&amp;(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&amp;&amp;"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&amp;&amp;f.load(function(){k(),e&amp;&amp;e(i.origUrl,h,g),j&amp;&amp;j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&amp;&amp;b++;return b}(),a)a.hasOwnProperty(n)&amp;&amp;(!c&amp;&amp;!--m&amp;&amp;(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&amp;&amp;a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&amp;&amp;l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&amp;&amp;c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i&lt;a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&amp;&amp;h(j,l);else Object(a)===a&amp;&amp;h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&amp;&amp;b.addEventListener&amp;&amp;(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&amp;&amp;g(k.readyState)&amp;&amp;(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
var _prum=[['id', '52e95df3abe53d2e33000000'], ['mark', 'firstbyte',
      (new Date()).getTime()]]; (function() {
      var s=document.getElementsByTagName('script')[0],
      p=document.createElement('script');
      p.async='async'; p.src='//rum-static.pingdom.net/prum.min.js';s.parentNode.insertBefore(p,s);})();
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-141606356-1", {"cookieDomain":"auto"});ga("set", "page", location.pathname + location.search + location.hash);ga("send", "pageview");ga('create', 'UA-189672-38', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"FsDzfQyg3fz36z0s-OHb7VNYvI_Fmc6HTHyqTuoYPEw"},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"markup":[{"requested":"short-text","variant":"abstract","view":"abstract","pisa":"medrxiv;2020.11.13.20231332v3"},{"requested":"short-text","variant":"abstract","view":"abstract","pisa":"medrxiv;2020.11.13.20231332v3"},{"requested":"full-text","variant":"full-text","view":"full","pisa":"medrxiv;2020.11.13.20231332v3"}],"nid":"565946","apath":"\/medrxiv\/early\/2022\/09\/30\/2020.11.13.20231332.atom","pisa":"medrxiv;2020.11.13.20231332v3","processed":["highwire_math"],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article"},"jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"disqus":{"domain":"medRxiv","url":"https:\/\/www.medrxiv.org\/content\/10.1101\/2020.11.13.20231332v3","title":"Multi-state network meta-analysis of cause-specific survival data","identifier":"node\/565946"},"panels_ajax_pane":{"new-28877068-b9cb-4641-830b-b6b4638c98bb":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022yWJ\\\\\\\/W3Si4iOcvMU6KVbAWz0Wg\\\\\\\/MfkIuZNKz6I0mD+5BNR9th0jjEjlXQHycTZ4EUfU+4WrhKArVPaefH82QjnnlCvhzXspk4f4KjESwCx3YcbYzeDSROi3iWAIO1nX\\\\\\\/zqhc4VqK7G5cjgpbSY2JR6W3XkXTjwWmKudMXtz39VjnT7X1GbLbWEiBlH40VrhN\\\\\\\/1fEMGfQEtMCHSDg77fIWKgSchSkfs1SfWcIQn5IIpAcHIKN7rcLPUsRLdzjMJG+zd7VGJbneHAG67deum+c1tRoBcGuiBq8I8S+WXhUWXThg3gZGP2r247Y9Vh18ppj8zvxoPf8mw8JcL2Ot\\\\\\\/JSbcDzMd8Vj+zr41YzZexeepSofxf0pY29mTPxZiQFu+y3utCET1LC5nkZV+PBdnjK\\\\\\\/DshJU+6M9+sYab6kWvK\\\\\\\/YYMahRkIJdDU1ZLgac7ceIlKW3lU\\\\\\\/DZjAFfYAcKolXSIeKG1ecDBVbIT47Y+wP5uohK0oNYQ0yw9RUS0q\\\\\\\/lSyNwERC\\\\\\\/PfKy8P8nHqLO4IMhMSbRbdl2pBToRC\\\\\\\/AK9F1ZCRKI82Xmljc4VSgqtH29sHel4liSwCDgY5+1CrXjpyVOtl2ZWsw9zvJoACb9NvxuASlQl1tdL855WsHGWvcv3j90BvDrQPfLt3R6lr9FpjP0UO0OOj+tYmf432GZrKK\\\\\\\/oZZXgnqV0YYeg3vq3BJMRtzd5lUwYgNsoElrLGyOTQumqkx76BAvHocW7rNhnxKg\\\\\\\/aLIgslreP1t6o9ulg+fVZzKt4\\\\\\\/BljnFEtrzj4DjL0ieizKLPzS\\\\\\\/GgXY9EgHhKrCqazWKGzdOOnaxFQX+XooCZyU\\\\\\\/SHTG4UhPOm4qbRNVXR0BKlE3iuftIqLq0C\\\\\\\/SlhgrGzNSw44LcLOj8\\\\\\\/S4kyAlEZwKHm9WwTrGYe2vBgo30KgJgnprEYhXi+E3FEJLDi0dwRarEi0Vi9Zq+nD0NXXa5uzdcdgVZkf2Hl7c0J9lgOpY+8veUnx1wwB69RsZPKSUUKEcbuNd8RCbBKyrVN9ilt+jNo+jIIl6Ta+h\\\\\\\/GswwD0VWyhtfLHuz9Cw6F75+CvReLZ61yA9aBtj3jVmBX7oTFI0GkZF9y9ZGRktKjy9y+OKRnjFU7JRgfj\\\\\\\/6Zu0ECpVqGqTJrJM3Fpu6Qs6I9cOdSr+6cZYbxvcSdDcUGqBz\\\\\\\/0+fWyD66woXu+bwTIrWYfUafkzeJty5J8IG8VBp8VLC0CSHENMxnRshUuoTHepG\\\\\\\/hoDl38Yh4p19cqZDjUctYb0IPrxG6ecucmRm+lmQ+5urC2ty5lOurBPrLWaQmXDdsxVLyFehj5a1rjSMiQ\\\\\\\/P6fG7NytYuQTG1ysjTKnIpO5s2sTP6YMeKRjnwxQEgQof+94agbjfsoPXaXoHD0pTIHqw=\\\u0022,\\\u0022iv\\\u0022:\\\u0022SNjJzfXDUMYtdp5ywGe96Q==\\\u0022,\\\u0022salt\\\u0022:\\\u0022f9d8845712f72c9fee5db7d9ff111eab\\\u0022}\u0022,\u0022hmac\u0022:\u00227ceac738566fca98e1a7854b234d6c7326adc63bcaa3c55356498a19f534e410\u0022}"},"urlIsAjaxTrusted":{"\/content\/10.1101\/2020.11.13.20231332v3.full":true},"ws_fl":{"width":100,"height":21},"ws_gpo":{"size":"","annotation":"","lang":"","callback":"","width":300},"color":{"logo":"https:\/\/www.medrxiv.org\/sites\/default\/files\/medrxiv_internal_logo.png"},"highwire_list_expand":{"is_collapsed":"1"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Ch2\u003EThank you for accepting cookies\u003C\/h2\u003E\u003Cp\u003EYou can now hide this message or find out more about cookies.\u003C\/p\u003E    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EMore info\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"\/help\/cookie-policy","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1,"trackUrlFragments":1},"jnl_biorxiv_styles":{"defaultJCode":"medrxiv"},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--&gt;&lt;!]]&gt;
  </script>
 </head>
 <body class="html not-front not-logged-in page-node page-node- page-node-565946 node-type-highwire-article context-content hw-default-jcode-medrxiv hw-article-type-article">
  <noscript>
   <iframe src="//www.googletagmanager.com/ns.html?id=GTM-P4HH5NV" height="0" width="0" style="display:none;visibility:hidden">
   </iframe>
  </noscript>
  <script type="text/javascript">
   (function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&amp;l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-P4HH5NV');
  </script>
  <div id="skip-link">
   <a href="#main-content" class="element-invisible element-focusable">
    Skip to main content
   </a>
  </div>
  <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
   <header id="section-header" class="section section-header">
    <div id="zone-branding" class="zone zone-branding clearfix print-display-block container-30">
     <div class="grid-15 prefix-1 region region-branding print-display-block" id="region-branding">
      <div class="region-inner region-branding-inner">
       <div class="branding-data clearfix">
        <div class="logo-img">
         <a href="/" rel="home" class="" data-icon-position="" data-hide-link-title="0">
          <img alt="medRxiv" src="https://www.medrxiv.org/sites/default/files/medrxiv_internal_logo.png"/>
         </a>
        </div>
       </div>
      </div>
     </div>
     <div class="grid-11 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
      <div class="region-inner region-branding-second-inner">
       <div class="block block-system block-menu block-main-menu block-system-main-menu odd block-without-title" id="block-system-main-menu">
        <div class="block-inner clearfix">
         <div class="content clearfix">
          <nav class="menubar-nav">
           <ul class="menu" role="menu">
            <li class="first leaf" role="menuitem">
             <a href="/" title="" class="" data-icon-position="" data-hide-link-title="0">
              Home
             </a>
            </li>
            <li class="leaf" role="menuitem">
             <a href="/content/about-medrxiv" class="" data-icon-position="" data-hide-link-title="0">
              About
             </a>
            </li>
            <li class="leaf" role="menuitem">
             <a href="/submit-a-manuscript" class="" data-icon-position="" data-hide-link-title="0">
              Submit
             </a>
            </li>
            <li class="last leaf" role="menuitem">
             <a href="/content/alertsrss" title="" class="" data-icon-position="" data-hide-link-title="0">
              ALERTS / RSS
             </a>
            </li>
           </ul>
          </nav>
         </div>
        </div>
       </div>
       <div class="block block-panels-mini block-biorxiv-search-box block-panels-mini-biorxiv-search-box even block-without-title" id="block-panels-mini-biorxiv-search-box">
        <div class="block-inner clearfix">
         <div class="content clearfix">
          <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_search_box">
           <div class="panel-panel panel-col">
            <div>
             <div class="panel-pane pane-highwire-seach-quicksearch">
              <div class="pane-content">
               <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/10.1101/2020.11.13.20231332v3.full" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8">
                <div>
                 <div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
                  <label class="element-invisible" for="search_rightsidebar_keywords_1644338563">
                   Search for this keyword
                  </label>
                  <input placeholder="Search" type="text" id="search_rightsidebar_keywords_1644338563" name="keywords" value="" size="60" maxlength="128" class="form-text"/>
                 </div>
                 <div class="button-wrapper button-mini">
                  <span class="icon-search">
                  </span>
                  <input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="search_rightsidebar_submit_1366896159" name="op" value="Search" class="form-submit"/>
                 </div>
                 <input type="hidden" name="form_build_id" value="form-KBs6smUOgBzfvAXeYc187LaZEnZ-oK4v4fi1_bd9i4w"/>
                 <input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0"/>
                </div>
               </form>
              </div>
             </div>
             <div class="panel-separator">
             </div>
             <div class="panel-pane pane-custom pane-2 advanced-search-link">
              <div class="pane-content">
               <a href="/search">
                Advanced Search
               </a>
              </div>
             </div>
            </div>
           </div>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
    <div id="zone-header" class="zone zone-header clearfix container-30">
    </div>
   </header>
   <section id="section-content" class="section section-content">
    <div id="zone-content" class="zone zone-content clearfix container-30">
     <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
      <div class="region-inner region-content-inner">
       <a id="main-content">
       </a>
       <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
        <div class="block-inner clearfix">
         <div class="content clearfix">
          <div class="panel-display panels-960-layout jcore-2col-layout">
           <div class="panel-row-wrapper clearfix">
            <div class="main-content-wrapper grid-17 suffix-1 alpha">
             <div class="panel-panel panel-region-content">
              <div class="inside">
               <div class="panel-pane pane-highwire-article-citation">
                <div class="pane-content">
                 <div class="highwire-article-citation highwire-citation-type-highwire-article node565946" data-node-nid="565946" id="node-565946--21736071098" data-pisa="medrxiv;2020.11.13.20231332v3" data-pisa-master="medrxiv;2020.11.13.20231332" data-apath="/medrxiv/early/2022/09/30/2020.11.13.20231332.atom" data-hw-author-tooltip-instance="">
                  <div class="highwire-cite highwire-cite-highwire-article highwire-citation-medrxiv-article-top clearfix has-author-tooltip">
                   <h1 class="highwire-cite-title" id="page-title">
                    Multi-state network meta-analysis of cause-specific survival data
                   </h1>
                   <div class="highwire-cite-authors">
                    <span class="highwire-citation-authors">
                     <span class="highwire-citation-author first hw-author-orcid-logo-wrapper" data-delta="0">
                      <a href="http://orcid.org/0000-0003-2686-9217" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon">
                       <span class="hw-icon-orcid hw-icon-color-orcid">
                       </span>
                       <span class="title element-invisible">
                        View ORCID Profile
                       </span>
                      </a>
                      <span class="nlm-given-names">
                       Jeroen P.
                      </span>
                      <span class="nlm-surname">
                       Jansen
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author hw-author-orcid-logo-wrapper" data-delta="1">
                      <a href="http://orcid.org/0000-0002-4479-8750" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon">
                       <span class="hw-icon-orcid hw-icon-color-orcid">
                       </span>
                       <span class="title element-invisible">
                        View ORCID Profile
                       </span>
                      </a>
                      <span class="nlm-given-names">
                       Devin
                      </span>
                      <span class="nlm-surname">
                       Incerti
                      </span>
                     </span>
                     ,
                     <span class="highwire-citation-author hw-author-orcid-logo-wrapper" data-delta="2">
                      <a href="http://orcid.org/0000-0002-3990-1848" target="_blank" class="hw-author-orcid-logo link-icon-only link-icon">
                       <span class="hw-icon-orcid hw-icon-color-orcid">
                       </span>
                       <span class="title element-invisible">
                        View ORCID Profile
                       </span>
                      </a>
                      <span class="nlm-given-names">
                       Thomas A.
                      </span>
                      <span class="nlm-surname">
                       Trikalinos
                      </span>
                     </span>
                    </span>
                   </div>
                   <div class="highwire-cite-metadata">
                    <span class="highwire-cite-metadata-doi highwire-cite-metadata">
                     <span class="label">
                      doi:
                     </span>
                     https://doi.org/10.1101/2020.11.13.20231332
                    </span>
                   </div>
                  </div>
                  <div id="hw-article-author-popups-node-565946--21736071098" style="display: none;">
                   <div class="author-tooltip-0">
                    <div class="author-tooltip-name">
                     Jeroen P. Jansen
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        *
                       </span>
                       <span class="nlm-institution">
                        Dept. Clinical Pharmacy, School of Pharmacy, University of California - San Francisco
                       </span>
                       , CA;
                       <span class="nlm-institution">
                        Precision HEOR
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Jeroen%2BP.%2BJansen%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Jansen%20JP&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link">
                      <a href="/search/author1%3AJeroen%2BP.%2BJansen%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                     <li class="author-orcid-link">
                      <a href="http://orcid.org/0000-0003-2686-9217" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       ORCID record for Jeroen P. Jansen
                      </a>
                     </li>
                     <li class="author-corresp-email-link last">
                      <span>
                       For correspondence:
                       <a href="mailto:jeroen.jansen@ucsf.edu" class="" data-icon-position="" data-hide-link-title="0">
                        jeroen.jansen@ucsf.edu
                       </a>
                      </span>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-1">
                    <div class="author-tooltip-name">
                     Devin Incerti
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        †
                       </span>
                       <span class="nlm-institution">
                        Previously at Precision HEOR
                       </span>
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Devin%2BIncerti%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Incerti%20D&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link">
                      <a href="/search/author1%3ADevin%2BIncerti%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                     <li class="author-orcid-link last">
                      <a href="http://orcid.org/0000-0002-4479-8750" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       ORCID record for Devin Incerti
                      </a>
                     </li>
                    </ul>
                   </div>
                   <div class="author-tooltip-2">
                    <div class="author-tooltip-name">
                     Thomas A. Trikalinos
                    </div>
                    <div class="author-tooltip-affiliation">
                     <span class="author-tooltip-text">
                      <div class="author-affiliation">
                       <span class="nlm-sup">
                        ‡
                       </span>
                       <span class="nlm-institution">
                        Departments of Health Services, Policy and Practice and of Biostatistics and Center for Evidence Synthesis in Health, Brown University School of Public Health
                       </span>
                       , Providence, RI
                      </div>
                     </span>
                    </div>
                    <ul class="author-tooltip-find-more">
                     <li class="author-tooltip-gs-link first">
                      <a href="/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Thomas%2BA.%2BTrikalinos%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on Google Scholar
                      </a>
                     </li>
                     <li class="author-tooltip-pubmed-link">
                      <a href="/lookup/external-ref?access_num=Trikalinos%20TA&link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       Find this author on PubMed
                      </a>
                     </li>
                     <li class="author-site-search-link">
                      <a href="/search/author1%3AThomas%2BA.%2BTrikalinos%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">
                       Search for this author on this site
                      </a>
                     </li>
                     <li class="author-orcid-link last">
                      <a href="http://orcid.org/0000-0002-3990-1848" target="_blank" class="" data-icon-position="" data-hide-link-title="0">
                       ORCID record for Thomas A. Trikalinos
                      </a>
                     </li>
                    </ul>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs">
                <div class="pane-content">
                 <div class="item-list">
                  <ul class="tabs inline panels-ajax-tab">
                   <li class="first">
                    <a href="/content/10.1101/2020.11.13.20231332v3" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:565946" data-trigger="" data-url-enabled="1">
                     Abstract
                    </a>
                    <a href="/panels_ajax_tab/biorxiv_tab_art/node:565946/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2020.11.13.20231332v3.full-text" class="panels-ajax-tab-tab" data-panel-name="article_tab_full_text" data-target-id="highwire_article_tabs" data-entity-context="node:565946" data-trigger="full-text" data-url-enabled="1">
                     Full Text
                    </a>
                    <a href="/panels_ajax_tab/article_tab_full_text/node:565946/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2020.11.13.20231332v3.article-info" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:565946" data-trigger="article-info" data-url-enabled="1">
                     Info/History
                    </a>
                    <a href="/panels_ajax_tab/biorxiv_tab_info/node:565946/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2020.11.13.20231332v3.article-metrics" class="panels-ajax-tab-tab" data-panel-name="article_tab_metrics" data-target-id="highwire_article_tabs" data-entity-context="node:565946" data-trigger="article-metrics" data-url-enabled="1">
                     Metrics
                    </a>
                    <a href="/panels_ajax_tab/article_tab_metrics/node:565946/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li>
                    <a href="/content/10.1101/2020.11.13.20231332v3.external-links" class="panels-ajax-tab-tab" data-panel-name="article_tab_data_code" data-target-id="highwire_article_tabs" data-entity-context="node:565946" data-trigger="external-links" data-url-enabled="1">
                     Data/Code
                    </a>
                    <a href="/panels_ajax_tab/article_tab_data_code/node:565946/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                   <li class="last">
                    <a href="/content/10.1101/2020.11.13.20231332v3.full.pdf+html" class="panels-ajax-tab-tab" data-panel-name="biorxiv_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:565946" data-trigger="full.pdf+html" data-url-enabled="1">
                     <i class="icon-file-alt">
                     </i>
                     Preview PDF
                    </a>
                    <a href="/panels_ajax_tab/biorxiv_tab_pdf/node:565946/1" rel="nofollow" style="display:none" class="js-crawler-link">
                    </a>
                   </li>
                  </ul>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-panel-tabs-container">
                <div class="pane-content">
                 <div data-panels-ajax-tab-preloaded="article_tab_full_text" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container">
                  <div class="panels-ajax-tab-loading" style="display:none">
                   <img class="loading" src="https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading"/>
                  </div>
                  <div class="panels-ajax-tab-wrap-article_tab_full_text">
                   <div class="panel-display panel-1col clearfix">
                    <div class="panel-panel panel-col">
                     <div>
                      <div class="panel-pane pane-highwire-markup">
                       <div class="pane-content">
                        <div class="highwire-markup">
                         <div xmlns="http://www.w3.org/1999/xhtml" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" class="content-block-markup" xmlns:xhtml="http://www.w3.org/1999/xhtml">
                          <div class="article fulltext-view">
                           <span class="highwire-journal-article-marker-start">
                           </span>
                           <div class="section abstract" id="abstract-1">
                            <h2 class="">
                             Abstract
                            </h2>
                            <p id="p-2">
                             Multiple randomized controlled trials, each comparing a subset of competing interventions, can be synthesized by means of a network meta-analysis to estimate relative treatment effects between all interventions in the evidence base. Often there is an interest in estimating the relative treatment effects regarding time-to-event outcomes. Cancer treatment effectiveness is frequently quantified by analyzing overall survival (OS) and progression-free survival (PFS). In this paper we introduce a method for the joint network meta-analysis of PFS and OS that is based on a time-inhomogeneous tri-state (stable, progression, and death) Markov model where time-varying transition rates and relative treatment effects are modeled with known parametric survival functions or fractional polynomials. The data needed to run these analyses can be extracted directly from published survival curves. We demonstrate use by applying the methodology to a network of trials for the treatment of non-small-cell lung cancer. The proposed approach allows the joint synthesis of OS and PFS, relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost-effectiveness analyses.
                            </p>
                           </div>
                           <div class="section" id="sec-1">
                            <h2 class="">
                             1 Introduction
                            </h2>
                            <p id="p-16">
                             Randomized controlled trials (RCTs) are considered the most appropriate study design to obtain evidence regarding relative treatment effects. However, an individual RCT rarely includes all alternative interventions of interest, and as such does not provide all the information needed to select the best alternative. Typically, the evidence base consists of multiple RCTs, each of which compares a subset of the interventions of interest. If each of these trials has at least one intervention in common with another trial such that the evidence base is represented by a single connected network, a network meta-analysis (NMA) can estimate relative treatment effects between all the competing interventions in the evidence base
                             <sup>
                              <a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">
                               1
                              </a>
                             </sup>
                             .
                            </p>
                            <p id="p-17">
                             Often there is an interest in estimating the relative treatment effects of alternative interventions regarding time-to-event outcomes. For example in oncology, treatment efficacy is often quantified by analyzing time from treatment initiation to the occurrence of a particular event. Very commonly studies report data on overall survival (OS), where the event is death from any cause, and on progression-free survival (PFS), where the event is death from any cause or disease progression, whichever occurred first
                             <sup>
                              <a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">
                               2
                              </a>
                             </sup>
                             .
                            </p>
                            <p id="p-18">
                             NMA of time-to-event outcomes with a single effect measure per study are based on the proportion of patients alive at a specific time point, median survival, or reported hazard ratio (HR)
                             <sup>
                              <a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">
                               3
                              </a>
                             </sup>
                             . The limitation of a NMA of survival at a specific time point is that we only focus on the cumulative effect of treatment at that time point and ignore the variation in effects over time up to, as well as beyond, that time point. NMAs of median survival times have similar limitations. The HR summarizes the treatment effect for the complete follow-up period of the trials, but only represents the treatment effect for each time point if the proportional hazards (PH) assumption holds. If the PH assumption is violated, trial specific HRs represent an average effect over the follow-up period, which can cause biased estimates in a NMA if trials have different lengths of follow-up.
                            </p>
                            <p id="p-19">
                             As an alternative to a NMA with a univariate treatment effect measure, we can also use a multivariate treatment effect measure that describes how the relative treatment effects change over time
                             <sup>
                              <a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">
                               3
                              </a>
                             </sup>
                             . Ouwens et al., Jansen, and Cope et al presented methods for NMA of time-to-event outcomes where the hazard functions of the interventions in a trial are modeled using known parametric survival functions or fractional polynomials and the difference in the parameters are considered the multi-dimensional treatment effects, which are synthesized across studies
                             <sup>
                              <a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">
                               4
                              </a>
                             </sup>
                             –7. By incorporating time-related parameters, these NMA models can be fitted more closely to the available data.
                            </p>
                            <p id="p-20">
                             Both PFS and OS of an intervention determine its value and can inform decision-making. In combination with a baseline survival function for a reference treatment, the multivariate NMA models embedded in parametric survival functions can form the basis for partitioned-survival cost-effectiveness models
                             <sup>
                              <a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">
                               8
                              </a>
                             </sup>
                             . Frequently, the pooled PFS and OS curves need to be extrapolated over time in order to obtain estimates of the expected quality adjusted life-years before and after disease progression. Since the separate meta-analyses of PFS and of OS data ignore the correlation between the outcomes, any required extrapolation may result in possible crossing of PFS and OS curves. A state-transition model with three health states – stable (pre-progression), progression, and death – with parametric hazard functions for the three corresponding transitions avoids this issue. If we have individual patient data (IPD) regarding time to progression, time to death, and censoring for all trials included in the NMA, we can estimate these hazard functions using a statistical model with the same tri-state structure and avoid any inconsistency between the clinical evidence synthesis and the economic evaluation
                             <sup>
                              <a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">
                               9
                              </a>
                             </sup>
                             . Reality though is that for most, if not all, trials there is no access to IPD and the synthesis has to be based on reported summary findings. Although reported Kaplan-Meier curves for PFS and OS can be digitized and a dataset of “virtual” IPD event-times can be created with the algorithm by Guyot et al., it does not provide the information needed to determine which time-to-progression data point corresponds to which time-to-death data point
                             <sup>
                              <a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">
                               10
                              </a>
                             </sup>
                             . Markov-state-transition NMA models have been presented for disease progression
                             <sup>
                              <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">
                               11
                              </a>
                             </sup>
                             ,
                             <sup>
                              <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">
                               12
                              </a>
                             </sup>
                             and competing risks
                             <sup>
                              <a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">
                               13
                              </a>
                             </sup>
                             based on aggregate level data, but these models assumed constant hazards for transitions between states.
                            </p>
                            <p id="p-21">
                             In this paper we introduce a method for the joint NMA of PFS and OS that is based on a tri-state (stable, progression, and death) transition model where time-varying hazard rates and relative treatment effects are modeled with known parametric survival functions or fractional polynomials. We illustrate parameter estimation based on aggregate level data.
                            </p>
                           </div>
                           <div class="section" id="sec-2">
                            <h2 class="">
                             2 Multi-state network meta-analysis framework
                            </h2>
                            <div id="sec-3" class="subsection">
                             <h3>
                              2.1 Model
                             </h3>
                             <p id="p-22">
                              At any time u, patients in study i randomized to treatment arm k can be in one of three health states: alive with stable disease (i.e. not progressed), alive and progressed, and dead expressed with S
                              <sub>
                               ik
                              </sub>
                              (u), P
                              <sub>
                               ik
                              </sub>
                              (u) and D
                              <sub>
                               ik
                              </sub>
                              (u), respectively, as shown in
                              <a id="xref-fig-1-1" class="xref-fig" href="#F1">
                               Figure 1
                              </a>
                              .
                              <span class="inline-formula" id="inline-formula-1">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-1.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-1.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and
                              <span class="inline-formula" id="inline-formula-2">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-2.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-2.gif"/>
                                </noscript>
                               </span>
                              </span>
                              are the hazard rates for disease progression, dying post-progression, and dying pre-progression.
                             </p>
                             <div id="F1" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F1.large.jpg?width=800&height=600&carousel=1" title="Relationship between stable disease (S), progression (P) and death (D) as used in the multi-state network meta-analysis model " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Relationship between stable disease (S), progression (P) and death (D) as used in the multi-state network meta-analysis model</span> </div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 1:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F1.medium.gif" width="440" height="202"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 1:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F1.medium.gif" width="440" height="202"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F1.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 1:" data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml">
                               <span class="fig-label">
                                Figure 1:
                               </span>
                               <span class="caption-title">
                                Relationship between stable disease (S), progression (P) and death (D) as used in the multi-state network meta-analysis model
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <p id="p-23">
                              A multi-state NMA that explicitly estimates each possible transition in a tri-state model and modeling time-varying hazard rates and relative treatment effects with known parametric survival functions or fractional polynomials can be expressed as follows:
                              <span class="disp-formula" id="disp-formula-1">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-2.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-2.gif"/>
                                </noscript>
                               </span>
                              </span>
                              with d
                              <sub>
                               1,11
                              </sub>
                              = d
                              <sub>
                               2,11
                              </sub>
                              =, …, = d
                              <sub>
                               B,11
                              </sub>
                              = 0foridentification where p
                              <sub>
                               1
                              </sub>
                              , …, p
                              <sub>
                               B
                              </sub>
                              are fractional powers and the round bracket notation denotes the Box-Tidwell transformation: u
                              <sup>
                               (p)
                              </sup>
                              = u
                              <sup>
                               p
                              </sup>
                              if p ≠ 0 and u
                              <sup>
                               (p)
                              </sup>
                              = ln(u) if p = 0.
                              <a id="xref-disp-formula-1-1" class="xref-disp-formula" href="#disp-formula-1">
                               Equation 1
                              </a>
                              also includes the situation of repeated powers, where p
                              <sub>
                               x
                              </sub>
                              = p
                              <sub>
                               y
                              </sub>
                              for at least 1 pair of indices (x, y), 1 ≤ x < y ≤ a−1, a ≤ x < y ≤ b − 1, or b ≤ x < y ≤ B − 3. In this situation,
                              <span class="inline-formula" id="inline-formula-3">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-3.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-3.gif"/>
                                </noscript>
                               </span>
                              </span>
                              is used instead of
                              <span class="inline-formula" id="inline-formula-4">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-4.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-4.gif"/>
                                </noscript>
                               </span>
                              </span>
                              itself. A complete set of flexible fractional polynomials can be created with p
                              <sub>
                               1
                              </sub>
                              , …, p
                              <sub>
                               B−3
                              </sub>
                              ∈ {−2, −1, −0.5, 0, 0.5, 1, 2}. α
                              <sub>
                               1,ik
                              </sub>
                              , α
                              <sub>
                               2,ik
                              </sub>
                              , …, α
                              <sub>
                               a,ik
                              </sub>
                              are regression coefficients that represent the scale and shape parameters of the log-hazard function describing the stable-to-progression transition in study i for study arm k. α
                              <sub>
                               a+1,ik
                              </sub>
                              , α
                              <sub>
                               a+2,ik
                              </sub>
                              , …, α
                              <sub>
                               b,ik
                              </sub>
                              are the regression coefficients that represent the log-hazard function for the stable-to-death transition. α
                              <sub>
                               b+1,ik
                              </sub>
                              , α
                              <sub>
                               b+2,ik
                              </sub>
                              , …, α
                              <sub>
                               B,ik
                              </sub>
                              are the regression coefficients that represent the scale and shape parameters of the log-hazard function describing the progression-to-death in study i for study arm k.
                             </p>
                             <p id="p-24">
                              The µ
                              <sub>
                               ·,i
                              </sub>
                              reflect the study effects regarding the scale and shape parameters in each study i. The δ
                              <sub>
                               ·,ik
                              </sub>
                              are the study specific true underlying relative treatment effects for the treatment in study arm k relative to the treatment in arm 1 of that trial (with δ
                              <sub>
                               ·,i1
                              </sub>
                              = 0 to ensure identification) regarding the scale and shape of the log-hazard function for the different transitions, which are drawn from a normal distribution with the mean effect for treatment t expressed in terms of the overall reference treatment 1,
                              <span class="inline-formula" id="inline-formula-5">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-5.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-5.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and with a between-study-heterogeneity covariance matrix Σ.
                              <span class="inline-formula" id="inline-formula-6">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-6.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-6.gif"/>
                                </noscript>
                               </span>
                              </span>
                              represents the relative treatment effect with treatment t in study arm k in study i relative to reference treatment 1 regarding the scale and shape parameters of the log-hazard functions.
                             </p>
                             <p id="p-25">
                              A fixed effect model is obtained by replacing
                              <span class="inline-formula" id="inline-formula-7">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-7.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-7.gif"/>
                                </noscript>
                               </span>
                              </span>
                              with
                              <span class="inline-formula" id="inline-formula-8">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-8.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-8.gif"/>
                                </noscript>
                               </span>
                              </span>
                              .
                             </p>
                             <p id="p-26">
                              The random effects model presented with
                              <a id="xref-disp-formula-1-2" class="xref-disp-formula" href="#disp-formula-1">
                               Equation 1
                              </a>
                              does not account for correlation between trial-specific δ
                              <sub>
                               ·,ik
                              </sub>
                              s in multiple-arm trials (>2 treatments). A simplified random effects model with only one heterogeneity parameter, e.g. for
                              <span class="inline-formula" id="inline-formula-9">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-9.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-9.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , can be easily extended to fit trials with three or more treatment arms by decomposition of a multivariate normal distribution as a series of conditional univariate distributions
                              <sup>
                               <a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">
                                14
                               </a>
                              </sup>
                              :
                              <span class="disp-formula" id="disp-formula-2">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-3.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-3.gif"/>
                                </noscript>
                               </span>
                              </span>
                              The vector of random effects follows a multivariate normal distribution, a
                              <sub>
                               i
                              </sub>
                              represents the number of arms in trial i (a
                              <sub>
                               i
                              </sub>
                              = 2, 3,) and
                              <span class="inline-formula" id="inline-formula-10">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-10.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-10.gif"/>
                                </noscript>
                               </span>
                              </span>
                              . The conditional univariate distribution for the random effect of arm k > 2, given all arms from 2 to k − 1, is:
                              <span class="disp-formula" id="disp-formula-3">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-4.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-4.gif"/>
                                </noscript>
                               </span>
                              </span>
                             </p>
                            </div>
                            <div id="sec-4" class="subsection">
                             <h3>
                              2.2 Data and likelihood
                             </h3>
                             <p id="p-27">
                              For this paper we assume there is no access to IPD for the trials included in the NMA. The parameters will be estimated based on the conditional survival probabilities regarding PFS and OS that can be infered from the published KM curves. (See
                              <a id="xref-sec-17-1" class="xref-sec" href="#sec-17">
                               Appendix A
                              </a>
                              for the algorithm outlining construction of the dataset.) The total follow-up time can be partitioned into M successive non-overlapping intervals indexed by m = 1, …, M. We refer to interval m as U
                              <sub>
                               m
                              </sub>
                              and write u ∈ U
                              <sub>
                               m
                              </sub>
                              to denote Δu
                              <sub>
                               m
                              </sub>
                              ≤ u < u
                              <sub>
                               m+1
                              </sub>
                              . The length of U
                              <sub>
                               m
                              </sub>
                              is Δu
                              <sub>
                               m
                              </sub>
                              = u
                              <sub>
                               m+1
                              </sub>
                              − u
                              <sub>
                               m
                              </sub>
                              . For each interval m, we propose a binomial likelihood for the conditional survival probabilities regarding PFS and OS at time point u relative to the time point at the beginning of the interval U
                              <sub>
                               m
                              </sub>
                              according to:
                              <span class="disp-formula" id="disp-formula-4">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-5.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-5.gif"/>
                                </noscript>
                               </span>
                              </span>
                              where
                              <span class="inline-formula" id="inline-formula-11">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-11.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-11.gif"/>
                                </noscript>
                               </span>
                              </span>
                              are the observed number of patients who have not yet experienced progression or death at time u in the m
                              <sup>
                               th
                              </sup>
                              interval in study i for treatment arm k and
                              <span class="inline-formula" id="inline-formula-12">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-12.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-12.gif"/>
                                </noscript>
                               </span>
                              </span>
                              are the observed number of patients who have not died at time u in that interval.
                              <span class="inline-formula" id="inline-formula-13">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-13.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-13.gif"/>
                                </noscript>
                               </span>
                              </span>
                              is the underlying conditional survival probability regarding PFS and
                              <span class="inline-formula" id="inline-formula-14">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-14.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-14.gif"/>
                                </noscript>
                               </span>
                              </span>
                              is the underlying conditional survival probability regarding OS,
                              <span class="inline-formula" id="inline-formula-15">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-15.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-15.gif"/>
                                </noscript>
                               </span>
                              </span>
                              and
                              <span class="inline-formula" id="inline-formula-16">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-16.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-16.gif"/>
                                </noscript>
                               </span>
                              </span>
                              are the corresponding sample sizes at the beginning of the interval.
                             </p>
                             <p id="p-28">
                              For the m
                              <sup>
                               th
                              </sup>
                              interval, the conditional probabilities
                              <span class="inline-formula" id="inline-formula-17">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-17.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-17.gif"/>
                                </noscript>
                               </span>
                              </span>
                              and
                              <span class="inline-formula" id="inline-formula-18">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-18.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-18.gif"/>
                                </noscript>
                               </span>
                              </span>
                              are related to the proportion of patients who are progression free (stable disease) S
                              <sub>
                               ik
                              </sub>
                              (u) and the proportion of patients with progressed disease P
                              <sub>
                               ik
                              </sub>
                              (u) according to:
                              <span class="disp-formula" id="disp-formula-5">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-6.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-6.gif"/>
                                </noscript>
                               </span>
                              </span>
                              Arbitrary hazard functions can be approximated with a set of discontinuous constant hazard rates over relative short successive time intervals. For each interval m, S
                              <sub>
                               ik
                              </sub>
                              (u), P
                              <sub>
                               ik
                              </sub>
                              (u), and death D
                              <sub>
                               ik
                              </sub>
                              (u) are related to the hazards
                              <span class="inline-formula" id="inline-formula-19">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-19.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-19.gif"/>
                                </noscript>
                               </span>
                              </span>
                              according to the following set of differential equations (See
                              <a id="xref-sec-18-1" class="xref-sec" href="#sec-18">
                               Appendix B
                              </a>
                              ):
                              <span class="disp-formula" id="disp-formula-6">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-7.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-7.gif"/>
                                </noscript>
                               </span>
                              </span>
                              In order to estimate the three parameters
                              <span class="inline-formula" id="inline-formula-20">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-20.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-20.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and
                              <span class="inline-formula" id="inline-formula-21">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-21.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-21.gif"/>
                                </noscript>
                               </span>
                              </span>
                              for each interval m, we need to define
                              <a id="xref-disp-formula-4-1" class="xref-disp-formula" href="#disp-formula-4">
                               Equation 4
                              </a>
                              ,
                              <a id="xref-disp-formula-5-1" class="xref-disp-formula" href="#disp-formula-5">
                               Equation 5
                              </a>
                              and
                              <a id="xref-disp-formula-6-1" class="xref-disp-formula" href="#disp-formula-6">
                               Equation 6
                              </a>
                              for at least two time points per interval. In order to improve identifiability of hazard rates in the presence of a small number of events, we use three time points per interval: 1) a time point at 1/3 of the length of the interval
                              <span class="inline-formula" id="inline-formula-22">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-22.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-22.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , which we define as
                              <span class="inline-formula" id="inline-formula-23">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-23.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-23.gif"/>
                                </noscript>
                               </span>
                              </span>
                              ; 2) a time point at 2/3 of the length of the interval
                              <span class="inline-formula" id="inline-formula-24">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-24.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-24.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , which we define as
                              <span class="inline-formula" id="inline-formula-25">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-25.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-25.gif"/>
                                </noscript>
                               </span>
                              </span>
                              ; and 3) the time point at the end of the interval u
                              <sub>
                               m+1
                              </sub>
                              . The obtained estimates of the hazards for interval m are assigned to the time point
                              <span class="inline-formula" id="inline-formula-26">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-26.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-26.gif"/>
                                </noscript>
                               </span>
                              </span>
                              for
                              <a id="xref-disp-formula-1-3" class="xref-disp-formula" href="#disp-formula-1">
                               Equation 1
                              </a>
                              .
                             </p>
                            </div>
                           </div>
                           <div class="section" id="sec-5">
                            <h2 class="">
                             3 Illustrative example
                            </h2>
                            <div id="sec-6" class="subsection">
                             <h3>
                              3.1 Evidence base
                             </h3>
                             <p id="p-29">
                              An example of the multi-state models is presented for a NMA of first line treatment of adult patients with metastatic EGFR+ non-squamous non-small-cell lung cancer (NSCLC) with gefitinib, erlotinib, afatinib, dacomitinib, or platinum-based doublet chemotherapy regimens. Thirteen RCTs were obtained with a systematic literature review (ARCHER1050
                              <sup>
                               <a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">
                                15
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">
                                16
                               </a>
                              </sup>
                              ; LUX-LUNG 7
                              <sup>
                               <a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">
                                17
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">
                                18
                               </a>
                              </sup>
                              ; LUX-LUNG 3
                              <sup>
                               <a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">
                                19
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">
                                20
                               </a>
                              </sup>
                              ; LUX-LUNG 6
                              <sup>
                               <a id="xref-ref-20-2" class="xref-bibr" href="#ref-20">
                                20
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">
                                21
                               </a>
                              </sup>
                              ; EURTAC
                              <sup>
                               <a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">
                                22
                               </a>
                               –
                               <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">
                                24
                               </a>
                              </sup>
                              ; ENSURE
                              <sup>
                               <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">
                                25
                               </a>
                              </sup>
                              ; OPTIMAL
                              <sup>
                               <a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">
                                26
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">
                                27
                               </a>
                              </sup>
                              ; First-SIGNAL
                              <sup>
                               <a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">
                                28
                               </a>
                              </sup>
                              ; WJTOG3405
                              <sup>
                               <a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">
                                29
                               </a>
                              </sup>
                              ; IPASS
                              <sup>
                               <a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">
                                30
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">
                                31
                               </a>
                              </sup>
                              ; NEJ002
                              <sup>
                               <a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">
                                32
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">
                                33
                               </a>
                              </sup>
                              ; Han2017
                              <sup>
                               <a id="xref-ref-34-1" class="xref-bibr" href="#ref-34">
                                34
                               </a>
                              </sup>
                              ; Yang2014
                              <sup>
                               <a id="xref-ref-35-1" class="xref-bibr" href="#ref-35">
                                35
                               </a>
                              </sup>
                              ,
                              <sup>
                               <a id="xref-ref-36-1" class="xref-bibr" href="#ref-36">
                                36
                               </a>
                              </sup>
                              ). The evidence network is presented in
                              <a id="xref-fig-2-1" class="xref-fig" href="#F2">
                               Figure 2
                              </a>
                              and the trial-specific PFS and OS curves are provided as supplementary information in
                              <a id="xref-sec-27-1" class="xref-sec" href="#sec-27">
                               Section C.1
                              </a>
                              .
                             </p>
                             <div id="F2" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F2.large.jpg?width=800&height=600&carousel=1" title="Evidence network of RCTs " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Evidence network of RCTs</span> </div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 2:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F2.medium.gif" width="362" height="440"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 2:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F2.medium.gif" width="362" height="440"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F2.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 2:" data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption">
                               <span class="fig-label">
                                Figure 2:
                               </span>
                               <span class="caption-title">
                                Evidence network of RCTs
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                            </div>
                            <div id="sec-7" class="subsection">
                             <h3>
                              3.2 Network meta-analysis to estimate relative treatment effects
                             </h3>
                             <p id="p-30">
                              The following model was used for the NMAs, which is a simplification of
                              <a id="xref-disp-formula-1-4" class="xref-disp-formula" href="#disp-formula-1">
                               Equation 1
                              </a>
                              to faciliate parameter estimation:
                              <span class="disp-formula" id="disp-formula-7">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-9.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-9.gif"/>
                                </noscript>
                               </span>
                              </span>
                              where u
                              <sup>
                               0
                              </sup>
                              = ln(u) and d
                              <sub>
                               1,11
                              </sub>
                              = 0, d
                              <sub>
                               2,11
                              </sub>
                              = 0, d
                              <sub>
                               3,11
                              </sub>
                              = 0, and d
                              <sub>
                               4,11
                              </sub>
                              = 0.
                             </p>
                             <p id="p-31">
                              When p
                              <sub>
                               1
                              </sub>
                              = 0 and α
                              <sub>
                               3,ik
                              </sub>
                              = 0, the log-hazard functions follow a Weibull distribution. When p
                              <sub>
                               1
                              </sub>
                              = 1 and α
                              <sub>
                               3,ik
                              </sub>
                              = 0 these log-hazard functions follow a Gompertz distribution. When {(p
                              <sub>
                               1
                              </sub>
                              , p
                              <sub>
                               2
                              </sub>
                              ) = (0, 0), (0, 1)} and α
                              <sub>
                               3,ik
                              </sub>
                              ≠ 0, the log-hazard functions follow a second order polynomial that are extensions of the Weibull and Gompertz model to allow for arc- and bathtub shaped log-hazard functions. When α
                              <sub>
                               6,ik
                              </sub>
                              = 0 this transition follows an exponential distribution. When α
                              <sub>
                               6,ik
                              </sub>
                              ≠ 0 the transition rates over time are modeled with a first order fractional polynomial of which Weibull and Gompertz are special cases.
                             </p>
                             <p id="p-32">
                              With this model we assume there is one between-study heterogeneity parameter, which is related to the relative treatment effects that act on the scale of the log-hazard function for the stable-to-progression transition: The δ
                              <sub>
                               1,ik
                              </sub>
                              are drawn from a normal distribution with the mean effect for treatment t expressed in terms of the overall reference treatment 1,
                              <span class="inline-formula" id="inline-formula-27">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-27.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-27.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and between study heterogeneity
                              <span class="inline-formula" id="inline-formula-28">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-28.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-28.gif"/>
                                </noscript>
                               </span>
                              </span>
                              . The treatment specific relative effects regarding the first
                              <span class="inline-formula" id="inline-formula-29">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-29.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-29.gif"/>
                                </noscript>
                               </span>
                              </span>
                              and second
                              <span class="inline-formula" id="inline-formula-30">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-30.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-30.gif"/>
                                </noscript>
                               </span>
                              </span>
                              shape parameters of the log-hazard function for the stable-to-progression transition were assumed to be fixed. If it is assumed that treatment has only a direct effect on the transitions from stable to progression, which can reasonably be defended when a particular treatment upon disease progression is discontinued, the model can be further simplified by setting
                              <span class="inline-formula" id="inline-formula-31">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-31.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-31.gif"/>
                                </noscript>
                               </span>
                              </span>
                              .
                             </p>
                             <p id="p-33">
                              The following prior distributions for the parameters of the model were used:
                              <span class="disp-formula" id="disp-formula-8">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-10.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-10.gif"/>
                                </noscript>
                               </span>
                              </span>
                             </p>
                            </div>
                            <div id="sec-8" class="subsection">
                             <h3>
                              3.3 Meta-analysis of absolute effects with overall reference treatment
                             </h3>
                             <p id="p-34">
                              A NMA provides estimates of relative treatment effects between the competing interventions (i.e. hazard ratios). In order to obtain estimates for the transition rates over time between health states for each treatment, we first need to estimate the time-varying transition rates for an overall reference treatment, defined as treatment 1, and subsequently apply the hazard ratios of each treatment relative to treatment 1 obtained with the NMA to these baseline transition rates. As a final step, these time-varying transition rates for each treatment can be transformed into the distribution S, P, and D over time, and PFS and OS curves. In this example gefitinib is defined as treatment 1, and a meta-analysis of gefitinib arms of the trials was performed to estimate baseline rates with the following fixed effects model:
                              <span class="disp-formula" id="disp-formula-9">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-11.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-11.gif"/>
                                </noscript>
                               </span>
                              </span>
                              We used the same data structure, likelihood, and link functions as used for the NMA. (See
                              <a id="xref-disp-formula-4-2" class="xref-disp-formula" href="#disp-formula-4">
                               Equation 4
                              </a>
                              ,
                              <a id="xref-disp-formula-5-2" class="xref-disp-formula" href="#disp-formula-5">
                               Equation 5
                              </a>
                              , and
                              <a id="xref-disp-formula-6-2" class="xref-disp-formula" href="#disp-formula-6">
                               Equation 6
                              </a>
                              ). The prior distribution for this model was:
                              <span class="disp-formula" id="disp-formula-10">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-12.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-12.gif"/>
                                </noscript>
                               </span>
                              </span>
                             </p>
                            </div>
                            <div id="sec-9" class="subsection">
                             <h3>
                              3.4 Parameter estimation
                             </h3>
                             <p id="p-35">
                              The parameters of the different models were estimated using a Markov Chain Monte Carlo (MCMC) method implemented in the JAGS software package
                              <sup>
                               <a id="xref-ref-37-1" class="xref-bibr" href="#ref-37">
                                37
                               </a>
                              </sup>
                              . All JAGS analyses were run using
                              <kbd>
                               R
                              </kbd>
                              statistical software
                              <sup>
                               <a id="xref-ref-38-1" class="xref-bibr" href="#ref-38">
                                38
                               </a>
                              </sup>
                              . See
                              <a id="xref-sec-28-1" class="xref-sec" href="#sec-28">
                               Section C.2
                              </a>
                              for the JAGS code for one of the models used to estimate relative treatment effects.
                             </p>
                             <p id="p-36">
                              If the sample size or number of PFS or OS related events in interval U
                              <sub>
                               ikm
                              </sub>
                              is relatively small then it may be challenging with the MCMC algorithm to distinguish between the “correct answer” for
                              <span class="inline-formula" id="inline-formula-32">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-32.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-32.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and
                              <span class="inline-formula" id="inline-formula-33">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-33.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-33.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and alternative estimates where either
                              <span class="inline-formula" id="inline-formula-34">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-34.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-34.gif"/>
                                </noscript>
                               </span>
                              </span>
                              or
                              <span class="inline-formula" id="inline-formula-35">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-35.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-35.gif"/>
                                </noscript>
                               </span>
                              </span>
                              . As such, we set a constraint to avoid that
                              <span class="inline-formula" id="inline-formula-36">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-36.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-36.gif"/>
                                </noscript>
                               </span>
                              </span>
                              and
                              <span class="inline-formula" id="inline-formula-37">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-37.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-37.gif"/>
                                </noscript>
                               </span>
                              </span>
                              is estimated to be zero. (See
                              <a id="xref-sec-28-2" class="xref-sec" href="#sec-28">
                               Section C.2
                              </a>
                              )
                             </p>
                             <p id="p-37">
                              The residual deviance and the deviance information criterion (DIC) were used to compare the goodness-of-fit of the competing models.
                              <sup>
                               <a id="xref-ref-39-1" class="xref-bibr" href="#ref-39">
                                39
                               </a>
                              </sup>
                              The DIC provides a measure of model fit that penalizes model complexity. In general, a more complex model results in a better fit to the data, demonstrating a smaller residual deviance. The model with the better trade-off between fit and parsimony has a lower DIC. A difference in the DIC of about 10 points can be considered meaningful.
                             </p>
                            </div>
                            <div id="sec-10" class="subsection">
                             <h3>
                              3.5 Results
                             </h3>
                             <p id="p-38">
                              For transparancy purposes we first present the results of the meta-analysis of treatment 1 (gefitinib), followed by the results of the NMA, and finally the PFS and OS curves obtained by applying the relative treatment effects obtained with the NMA to the pooled results for treatment 1.
                             </p>
                             <p id="p-39">
                              For this example we used the following competing models for the meta-analysis of treatment 1:
                             </p>
                             <ul class="list-simple" id="list-1">
                              <li id="list-item-1">
                               <p id="p-40">
                                - SP 2nd order FP(01); SD Weibull; PD Weibull. This is a fixed effects second order fractional polynomial with time transformations according to p
                                <sub>
                                 1
                                </sub>
                                = 0 and p
                                <sub>
                                 2
                                </sub>
                                = 1 for the stable-to-progression (SP) transition; a Weibull distribution for the stable-to-death (SD) transition; and a Weibull distribution for the progression-to-death (PD) transition. (See
                                <a id="xref-disp-formula-9-1" class="xref-disp-formula" href="#disp-formula-9">
                                 Equation 9
                                </a>
                                )
                               </p>
                              </li>
                              <li id="list-item-2">
                               <p id="p-41">
                                - SP 2nd order FP(01); SD Weibull; PD exponential
                               </p>
                              </li>
                              <li id="list-item-3">
                               <p id="p-42">
                                - SP 2nd order FP(01); SD exponential; PD Weibull
                               </p>
                              </li>
                              <li id="list-item-4">
                               <p id="p-43">
                                - SP 2nd order FP(01); SD exponential; PD exponential
                               </p>
                              </li>
                              <li id="list-item-5">
                               <p id="p-44">
                                - SP 2nd order FP(00); SD exponential; PD Weibull (See
                                <a id="xref-disp-formula-9-2" class="xref-disp-formula" href="#disp-formula-9">
                                 Equation 9
                                </a>
                                with p
                                <sub>
                                 1
                                </sub>
                                = p
                                <sub>
                                 2
                                </sub>
                                = 0)
                               </p>
                              </li>
                              <li id="list-item-6">
                               <p id="p-45">
                                - SP Weibull; SD Weibull; PD exponential
                               </p>
                              </li>
                              <li id="list-item-7">
                               <p id="p-46">
                                - SP Weibull; SD exponential; PD Weibull
                               </p>
                              </li>
                              <li id="list-item-8">
                               <p id="p-47">
                                - SP Weibull; SD exponential; PD exponential
                               </p>
                              </li>
                              <li id="list-item-9">
                               <p id="p-48">
                                - SP Gompertz; SD exponential; PD Weibull
                               </p>
                              </li>
                              <li id="list-item-10">
                               <p id="p-49">
                                - SP Gompertz; SD exponential; PD exponential
                               </p>
                              </li>
                             </ul>
                             <p id="p-50">
                              The model fit statistics are presented in
                              <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">
                               Table 1
                              </a>
                              . The models with a second order fractional polynomial for the the stable-to-progression transition resulted in the smallest deviance and DIC. The models assuming a Gompertz distribution for this transition resulted in the largest deviance and DIC. The parameter estimates of a selection of four competing models that show different patterns of time-varying hazards for the three transitions between the health states are presented in
                              <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">
                               Table 2
                              </a>
                              . The actual time-varying hazard rates and corresponding PFS and OS curves are plotted in
                              <a id="xref-fig-3-1" class="xref-fig" href="#F3">
                               Figure 3
                              </a>
                              .
                             </p>
                             <div id="T1" class="table pos-float">
                              <div class="table-inline table-callout-links">
                               <div class="callout">
                                <span>
                                 View this table:
                                </span>
                                <ul class="callout-links">
                                 <li class="view-inline first">
                                  <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/566960/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                   View inline
                                  </a>
                                 </li>
                                 <li class="view-popup">
                                  <a href="/highwire/markup/566960/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                   View popup
                                  </a>
                                 </li>
                                 <li class="download-ppt last">
                                  <a href="/highwire/powerpoint/566960" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                   Download powerpoint
                                  </a>
                                 </li>
                                </ul>
                               </div>
                              </div>
                              <div class="table-caption">
                               <span class="table-label">
                                Table 1:
                               </span>
                               <span class="caption-title">
                                Model fit criteria for alternative meta-analysis and network meta-analysis models
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <div id="T2" class="table pos-float">
                              <div class="table-inline table-callout-links">
                               <div class="callout">
                                <span>
                                 View this table:
                                </span>
                                <ul class="callout-links">
                                 <li class="view-inline first">
                                  <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/566985/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                   View inline
                                  </a>
                                 </li>
                                 <li class="view-popup">
                                  <a href="/highwire/markup/566985/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                   View popup
                                  </a>
                                 </li>
                                 <li class="download-ppt last">
                                  <a href="/highwire/powerpoint/566985" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                   Download powerpoint
                                  </a>
                                 </li>
                                </ul>
                               </div>
                              </div>
                              <div class="table-caption">
                               <span class="table-label">
                                Table 2:
                               </span>
                               <span class="caption-title">
                                Absolute treatment effect parameters regarding time-varying transition rates with treatment 1 for a selection of alternative meta-analysis models
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <div id="F3" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F3.large.jpg?width=800&height=600&carousel=1" title="Pooled estimates of transition rates between stable and progression (SP), stable and death (SD), and progression and death (PD), and PFS and OS curves with treatment 1 from a selection of alternative multi-state fixed effects meta-analysis models " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Pooled estimates of transition rates between stable and progression (SP), stable and death (SD), and progression and death (PD), and PFS and OS curves with treatment 1 from a selection of alternative multi-state fixed effects meta-analysis models</span> </div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 3:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F3.medium.gif" width="440" height="437"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 3:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F3.medium.gif" width="440" height="437"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F3.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 3:" data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption">
                               <span class="fig-label">
                                Figure 3:
                               </span>
                               <span class="caption-title">
                                Pooled estimates of transition rates between stable and progression (SP), stable and death (SD), and progression and death (PD), and PFS and OS curves with treatment 1 from a selection of alternative multi-state fixed effects meta-analysis models
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <p id="p-51">
                              For the NMA the following models were evaluated:
                             </p>
                             <ul class="list-simple" id="list-2">
                              <li id="list-item-11">
                               <p id="p-52">
                                - SP 2nd order FP(01) FE3; SD Weibull; PD Weibull FE1(scale). This is a second order fractional polynomial with time transformations according to p
                                <sub>
                                 1
                                </sub>
                                = 0 and p
                                <sub>
                                 2
                                </sub>
                                = 1 for the stable-to-progression transition with fixed effects relative treatment effects on all 3 parameters (α
                                <sub>
                                 1
                                </sub>
                                , α
                                <sub>
                                 2
                                </sub>
                                , α
                                <sub>
                                 3
                                </sub>
                                ); a Weibull distribution for the stable-to-death transition without relative treatment effects; and a Weibull distribution for the progression-to-death transition with fixed effects relative treatment effects only on the scale parameter (α
                                <sub>
                                 5
                                </sub>
                                ).
                               </p>
                              </li>
                              <li id="list-item-12">
                               <p id="p-53">
                                - SP 2nd order FP(01) FE3; SD Weibull; PD exponential FE
                               </p>
                              </li>
                              <li id="list-item-13">
                               <p id="p-54">
                                - SP 2nd order FP(01) FE3; SD Weibull; PD exponential. This model only has relative treatment effects applied to the stable-to-progression transition.
                               </p>
                              </li>
                              <li id="list-item-14">
                               <p id="p-55">
                                - SP 2nd order FP(01) FE3; SD exponential; PD Weibull FE1(scale)
                               </p>
                              </li>
                              <li id="list-item-15">
                               <p id="p-56">
                                - SP 2nd order FP(01) FE3; SD exponential; PD Weibull
                               </p>
                              </li>
                              <li id="list-item-16">
                               <p id="p-57">
                                - SP 2nd order FP(01) FE3; SD exponential; PD exponential
                               </p>
                              </li>
                              <li id="list-item-17">
                               <p id="p-58">
                                - SP Weibull FE2; SD Weibull; PD exponential FE
                               </p>
                              </li>
                              <li id="list-item-18">
                               <p id="p-59">
                                - SP Weibull FE2; SD exponential; PD Weibull FE1(scale)
                               </p>
                              </li>
                              <li id="list-item-19">
                               <p id="p-60">
                                - SP Weibull FE2; SD exponential; PD Weibull
                               </p>
                              </li>
                              <li id="list-item-20">
                               <p id="p-61">
                                - SP Weibull FE2; SD exponential; PD exponential
                               </p>
                              </li>
                              <li id="list-item-21">
                               <p id="p-62">
                                - SP 2nd order FP(01) RE3; SD Weibull; PD Weibull FE1(scale). This is the random effects model according to
                                <a id="xref-disp-formula-7-1" class="xref-disp-formula" href="#disp-formula-7">
                                 Equation 7
                                </a>
                                with p
                                <sub>
                                 1
                                </sub>
                                = 0 and p
                                <sub>
                                 2
                                </sub>
                                = 1.
                               </p>
                              </li>
                              <li id="list-item-22">
                               <p id="p-63">
                                - SP 2nd order FP(01) RE3; SD Weibull; PD exponential FE
                               </p>
                              </li>
                              <li id="list-item-23">
                               <p id="p-64">
                                - SP 2nd order FP(01) RE3; SD exponential; PD Weibull FE1(scale)
                               </p>
                              </li>
                              <li id="list-item-24">
                               <p id="p-65">
                                - SP Weibull RE2; SD exponential; PD Weibull FE1(scale)
                               </p>
                              </li>
                             </ul>
                             <p id="p-66">
                              The NMA models that assumed a second order fractional polynomial for the stable-to-progression transition had a lower deviance and DIC than the corresponding simpler models assuming a Weibull distribution for this transition. The models with a Weibull distribution for the stable-to-death transition had a lower DIC than the corresponding models assuming an exponential distribution for this transition. Models with a Weibull distribution for the progression-to-death transition were not a meaningful improvement over the corresponding models that assumed an exponential distribution for this transition. Comparing models that assumed a relative treatment effect for the progression-to-death transition with the corresponding models without this relative treatment effect indicates that a relative effect may be a relevant component to include for this transition in some models. The second order fractional polynomial and Weibull random effects models performed better than their fixed effects equivalents, indicating that incorporating between-study heterogeneity is important.
                             </p>
                             <p id="p-67">
                              Parameter estimates for the random effects second order fractional polynomial model (SP 2nd order FP(01) RE3; SD Weibull; PD Weibull FE1(scale)), the random effects Weibull model (SP Weibull RE2; SD exponential; PD Weibull FE1(scale), and two fixed effects models (SP Weibull FE2; SD Weibull; PD exponential FE and SP Weibull FE2; SD exponential; PD exponential) are presented in
                              <a id="xref-table-wrap-3-1" class="xref-table" href="#T3">
                               Table 3
                              </a>
                              . The corresponding time-varying HRs with treatment relative to treatment 1 for the stable to progression transitions are presented in
                              <a id="xref-fig-4-1" class="xref-fig" href="#F4">
                               Figure 4
                              </a>
                              , and the constant HRs for the progression-to-death transition in
                              <a id="xref-fig-5-1" class="xref-fig" href="#F5">
                               Figure 5
                              </a>
                              . (Please note that we did not assume a relative treatment effect for the stable-to-death transition). Applying the relative treatment effect parameter estimates describing the HRs over time obtained with these NMA models to the parameter estimates of the models used for the analysis of treatment 1, we obtain the PFS and OS curves by treatment, as presented in
                              <a id="xref-fig-6-1" class="xref-fig" href="#F6">
                               Figure 6
                              </a>
                              . In order to illustrate the width of the 95 credible intervals of these survival curves due to the uncertainty in the time-varying HRs, we ignored the uncertainty for the reference treatment 1. (If the uncertainty of the meta-analysis would have been incorporated as well, the 95 credible intervals would have been a bit wider.)
                             </p>
                             <div id="T3" class="table pos-float">
                              <div class="table-inline table-callout-links">
                               <div class="callout">
                                <span>
                                 View this table:
                                </span>
                                <ul class="callout-links">
                                 <li class="view-inline first">
                                  <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/566981/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                   View inline
                                  </a>
                                 </li>
                                 <li class="view-popup">
                                  <a href="/highwire/markup/566981/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                   View popup
                                  </a>
                                 </li>
                                 <li class="download-ppt last">
                                  <a href="/highwire/powerpoint/566981" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                   Download powerpoint
                                  </a>
                                 </li>
                                </ul>
                               </div>
                              </div>
                              <div class="table-caption">
                               <span class="table-label">
                                Table 3:
                               </span>
                               <span class="caption-title">
                                Relative treatment effect parameters regarding time-varying transition rates for a selection of alternative network meta-analysis models
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <div id="F4" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F4.large.jpg?width=800&height=600&carousel=1" title="Estimates of hazard ratios from stable to progression with treatments 2-5 relative to treatment 1 from a selection of alternative multi-state network meta-analysis models " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Estimates of hazard ratios from stable to progression with treatments 2-5 relative to treatment 1 from a selection of alternative multi-state network meta-analysis models</span> </div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 4:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F4.medium.gif" width="440" height="437"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 4:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F4.medium.gif" width="440" height="437"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F4.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 4:" data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F4.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption">
                               <span class="fig-label">
                                Figure 4:
                               </span>
                               <span class="caption-title">
                                Estimates of hazard ratios from stable to progression with treatments 2-5 relative to treatment 1 from a selection of alternative multi-state network meta-analysis models
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <div id="F5" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F5.large.jpg?width=800&height=600&carousel=1" title="Estimates of hazard ratios from progression to death with treatments 2-5 relative to treatment 1 from a selection of alternative multi-state network meta-analysis models " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Estimates of hazard ratios from progression to death with treatments 2-5 relative to treatment 1 from a selection of alternative multi-state network meta-analysis models</span> </div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 5:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F5.medium.gif" width="440" height="437"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 5:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F5.medium.gif" width="440" height="437"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F5.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 5:" data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F5.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption">
                               <span class="fig-label">
                                Figure 5:
                               </span>
                               <span class="caption-title">
                                Estimates of hazard ratios from progression to death with treatments 2-5 relative to treatment 1 from a selection of alternative multi-state network meta-analysis models
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                             <div id="F6" class="fig pos-float type-figure odd">
                              <div class="highwire-figure">
                               <div class="fig-inline-img-wrapper">
                                <div class="fig-inline-img">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F6.large.jpg?width=800&height=600&carousel=1" title="Estimates of progression-free survival and overall survival for treatment 1-5 obtained with a selection of alternative multi-state network meta-analysis models " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Estimates of progression-free survival and overall survival for treatment 1-5 obtained with a selection of alternative multi-state network meta-analysis models</span> </div>' data-icon-position="" data-hide-link-title="0">
                                  <span class="hw-responsive-img">
                                   <img class="highwire-fragment fragment-image lazyload" alt="Figure 6:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F6.medium.gif" width="440" height="437"/>
                                   <noscript>
                                    <img class="highwire-fragment fragment-image" alt="Figure 6:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F6.medium.gif" width="440" height="437"/>
                                   </noscript>
                                  </span>
                                 </a>
                                </div>
                               </div>
                               <ul class="highwire-figure-links inline">
                                <li class="download-fig first">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F6.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure 6:" data-icon-position="" data-hide-link-title="0">
                                  Download figure
                                 </a>
                                </li>
                                <li class="new-tab last">
                                 <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F6.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                  Open in new tab
                                 </a>
                                </li>
                               </ul>
                              </div>
                              <div class="fig-caption">
                               <span class="fig-label">
                                Figure 6:
                               </span>
                               <span class="caption-title">
                                Estimates of progression-free survival and overall survival for treatment 1-5 obtained with a selection of alternative multi-state network meta-analysis models
                               </span>
                               <div class="sb-div caption-clear">
                               </div>
                              </div>
                             </div>
                            </div>
                           </div>
                           <div class="section" id="sec-11">
                            <h2 class="">
                             4 Discussion
                            </h2>
                            <p id="p-68">
                             With this paper we present a method for the joint NMA of PFS and OS that is based on a tri-state transition model. This method extends existing parametric NMA methods for time-to-event data
                             <sup>
                              <a id="xref-ref-4-2" class="xref-bibr" href="#ref-4">
                               4
                              </a>
                              –
                              <a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">
                               7
                              </a>
                             </sup>
                             by defining the structural relationship between PFS and OS according to the stable, progression, and death states that define the course of disease over time. Instead of modeling the time-varying hazard rates for PFS and OS separately, we model the time-varying transition rates between the three health states simultaneously. The primary advantage of this evidence synthesis framework is that estimates for PFS and OS remain consistent over time.
                            </p>
                            <p id="p-69">
                             The primary reason to propose the method described in this paper is to facilitate parameterization of multi-state cost-effectiveness models based on summary level data. In order to do so, we describe the conditional survival probability for PFS and OS with two separate binomial likelihoods for a given interval m (See
                             <a id="xref-disp-formula-4-3" class="xref-disp-formula" href="#disp-formula-4">
                              Equation 4
                             </a>
                             ), and capture their relationship with
                             <a id="xref-disp-formula-5-3" class="xref-disp-formula" href="#disp-formula-5">
                              Equation 5
                             </a>
                             and
                             <a id="xref-disp-formula-6-3" class="xref-disp-formula" href="#disp-formula-6">
                              Equation 6
                             </a>
                             . The implication of this approach is that we assume that
                             <span class="inline-formula" id="inline-formula-38">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-38.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-38.gif"/>
                               </noscript>
                              </span>
                             </span>
                             is independent from
                             <span class="inline-formula" id="inline-formula-39">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-39.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-39.gif"/>
                               </noscript>
                              </span>
                             </span>
                             or
                             <span class="inline-formula" id="inline-formula-40">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-40.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-40.gif"/>
                               </noscript>
                              </span>
                             </span>
                             , or both
                             <span class="inline-formula" id="inline-formula-41">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-41.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-41.gif"/>
                               </noscript>
                              </span>
                             </span>
                             and
                             <span class="inline-formula" id="inline-formula-42">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-42.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-42.gif"/>
                               </noscript>
                              </span>
                             </span>
                             . The correlation between conditional PFS and conditional OS is explained by shared parameters
                             <span class="inline-formula" id="inline-formula-43">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-43.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-43.gif"/>
                               </noscript>
                              </span>
                             </span>
                             and
                             <span class="inline-formula" id="inline-formula-44">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-44.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-44.gif"/>
                               </noscript>
                              </span>
                             </span>
                             . For the purposes of decision making, the uncertainty in estimates are as important, if not more important, than the point estimates themselves. If the structural assumption regarding the relationship between the likelihoods for conditional PFS and OS does not capture their correlation appropriately, the precision in some or all of the transition rates, and therefore OS, will be overestimated. We perfored a simple simulation to assess the performance of estimating the hazard rates for the three transitions in a given time interval using the three conditional PFS and OS data points for that interval. Overall, the coverage probabilities of the 95% credible intervals for the hazard rates can be considered acceptable. (See
                             <a id="xref-sec-29-1" class="xref-sec" href="#sec-29">
                              Section C.3
                             </a>
                             for more detail.) However, more elaborate simulation studies are recommended to investigate this in more detail.
                            </p>
                            <p id="p-70">
                             To facilitate parameter estimation, we opted to use three conditional PFS and three conditional OS data points for each time interval. In principle, two conditional PFS and OS data points (i.e. four data points in total) would be sufficient to estimate the three constant hazard rates corresponding to the possible transitions in a given interval. When the number of events are small, however, the MCMC algortithm may not be able to distinguish between the “correct solutions” for the three hazard rates and alternative solutions corresponding to a situation where either
                             <span class="inline-formula" id="inline-formula-45">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-45.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-45.gif"/>
                               </noscript>
                              </span>
                             </span>
                             or
                             <span class="inline-formula" id="inline-formula-46">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-46.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-46.gif"/>
                               </noscript>
                              </span>
                             </span>
                             equates zero. By using three conditional PFS and OS data points for each time interval, this is less likely to be the case. However, a longer time interval for which the hazards are assummed to be constant is needed (e.g. a 3-month interval) than if two conditional PFS and OS data points would have been used (e.g. a 2-month interval). Further research is needed to define the optimal length of intervals and number of data points to use per interval given the oberved number of events in an interval, the population size at risk at the beginning of the interval, and rate of change of the hazards over time. In our example, we also used a likelihood constraint to avoid
                             <span class="inline-formula" id="inline-formula-47">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-47.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-47.gif"/>
                               </noscript>
                              </span>
                             </span>
                             or
                             <span class="inline-formula" id="inline-formula-48">
                              <span class="highwire-responsive-lazyload">
                               <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-48.gif"/>
                               <noscript>
                                <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-48.gif"/>
                               </noscript>
                              </span>
                             </span>
                             equate zero.
                            </p>
                            <p id="p-71">
                             For the illustrative example we used a subset of the theoretically possible competing models available within the proposed framework by making simplifying structural assumptions to facilitate parameter estimation. First, we assumed that a relative treatment effect for the stable-to-death transition was not needed reflecting the belief that differences in survival between treatments are only due to differences in delayed or avoided tumor progression, and not due to other treatment related (adverse) events. Second, we assumed that a function more complex than a first order fractional polynomial with a constant relative treatment effect was not required for the progression-to-death transition because this transition is conditional upon experiencing progression and modeled in relation to follow-up time. One could even argue that a relative treatment effect for this transition is not needed when treatment is discontinued upon progression. However, the DIC indicated that adding this parameter to the models resulted in a meaningful improvement for the example analyses, which is primarily related to the PBDC trials. Reasons to include a treatment effect parameter for the progression-to-death transition is treatment cross-over upon progression in a subset of trials, if post-progression treatment between trial arms differ, or if the post-progression mortality patterns is expected to differ between treatments due to other reasons. Third, out of the possible fractional polynomials, we only evaluated exponential, Weibull and Gompertz models and their extensions where the additional parameter related the log-hazard to time or log-time. We did not consider any of the negative power transformations of time, primarily because these functions do not link to known survival distributions and the 2nd order models we did use have already the flexibility to capture arc-shaped hazard functions.
                            </p>
                            <p id="p-72">
                             This brings us to the point of model selection. When evaluating competing models, both model fit criteria as well as clinical or biologic plausibility need to considered. In this paper we used DIC to inform model selection among the presented alternatives, but estimating the total residual deviance and comparing this to the number of datapoints would be a useful addition as it tells us how well the models are actually fitting the data. Evaluating all possible competing models available within the proposed framework regarding fit of to the data is not feasible from a practical perspective. Even if we are estimating DIC using only a small number of exploratory MCMC samples, the computational burden is still substantial. A priori, we need to define the relevant subset of models to compare. Factors to consider include: (i) the required flexibility to capture time-related patterns of the hazard functions for the different transitions; (ii) which transitions do we expect to vary by treatment; (iii) does treatment only impact scale or also shape parameters; (iv) how do we incorporate between-study heterogeneity; and (v) availability of data in relation to the number of parameters to estimate. In general, for the stable-to-progression transition, the degree of flexibility of the considered function is arguably most important as these hazards may vary substantially over time and between treatments. For the progression-to-death transition, the stability of estimates is arguably most important given the potential need for overall survival extrapolation and the notion that any between-treatment contrasts are most likely primarily observed for the stable-to-progression transitions. For the stable-to-death transition, the importance of the appropriate function depends on the expected hazard rates in comparison to the rates for the other transitions. If the stable-to-death transition rates are relatively low, model mis-specification may have a limited impact. In addition, these transitions may reflect background-mortality and, as such, we do not need treatment effect-parameters. Future research is needed to inform a model selection strategy or algorithm that results in a set of models that is likely to cover the distribution of transition rates between the health states, results in realistic extrapolations over time, and, given the computational burden of the more complex models for large datasets, can be evaluated in a reasonable amount of time.
                            </p>
                            <p id="p-73">
                             The proposed evidence synthesis framework relates directly to clock forward time-inhomogeneous Markov models where treatment specific transition rates between health states are only a function of time in the model. A frequently used approach for cost-effectiveness analysis of cancer treatments are partitioned survival models. However, the main limitation is that extrapolated parametric PFS and OS curves for a given treatment may cross. This will not be case with Markov models and, as such, are preferred as long as time-varying transition rates between health states can be estimated that reflect the actual PFS and OS of the treatments compared. As far as we know, the method presented in this paper is the first to facilitate this based on reported aggregate level data. In order to obtain the parameter estimates for a cost-effectiveness analysis we need to define a baseline model and a NMA model. The baseline model provides estimates for the absolute effect with the reference treatment, which in this case are the time-varying log-hazard rates between each of the three health states. The NMA model provides estimates of the relative treatment effects of each intervention in the network relative to the reference treatment, which in this case are the time-varying log hazards ratios. The absolute effect with each treatment is obtained by adding the relative treatment effects from the NMA to the absolute effect with the reference treatment from the baseline model, and subsequently transforming these to the natural scale by inverting the log-link function
                             <sup>
                              <a id="xref-ref-40-1" class="xref-bibr" href="#ref-40">
                               40
                              </a>
                             </sup>
                             . In the current example we used the RCT evidence base to estimate the baseline meta-analysis model as well as the NMA model. However, for an actual cost-effectiveness analysis it may be more appropriate to use a different evidence base that better reflects expected outcomes with the reference treatment for the baseline model, such as a long-term routine practice observational studies.
                            </p>
                            <p id="p-74">
                             The estimates obtained with the proposed evidence synthesis models can also be used in semi-Markov individual simulation models (i.e. models where some transitions are affected by time in an intermediate state). For example, imagine a cost-effectiveness model of first-line cancer treatment consisting of the three health states stable, progression, and death. The stable-to-progression and stable-to-death transitions can be estimated based on first-line trials using the proposed multi-state (network) meta-analysis method. The progression-to-death transitions in these trials no longer represent current standard of care and we need to estimate these transition rates based on overall survival data from second line trials of current treatment using a separate (network) meta-analysis model. Similarly, we can use the proposed evidence synthesis models in the context of semi-Markov simulation models describing sequential cancer treatment. Imagine a model consisting of four health states: 1) stable disease with first line treatment, 2) progression with first line treatment/stable disease with second line treatment, 3) progression with second line treatment, and 4) death. First-line treatment transitions from stable-to-progression and stable-to-death are estimated with one multi-state (network) meta-analysis model based on first line trials, and the second-line treatment transitions from stable-to-progression, stable-to-death, and progression to death (reflecting third line treatment and beyond) are estimated with another multi-state (network) meta-analysis model based on second line trials. In general, for the transitions in a simulation model for which the “clock is reset” a separate multi-state (network) meta-analysis needs to be performed.
                            </p>
                            <p id="p-75">
                             Time-varying transition rates from an intermediate health state, e.g. progressed disease, are typically modeled as a function of time since entering that state using (time-reset) semi Markov models. For clock-forward Markov models, where transition rates are only a function of time in the model, typically constant transition rates are used for the transitions from intermediate health states. However, we want to highlight that this is not a requirement and time-varying transition rates in a clock-forward Markov model can be defended in certain situations. For example, a monotonically decreasing hazard function (corresponding to Weibull distribution) for the progression-to-death transition means that an individual progressing after (say) 6 months has a greater probability of dying in the subsequent month than (say) an individual who progressed after 24 months. This reflects the possible scenario that more severe individuals or individuals without any treatment response are more likely to die faster once progressed than less severe patients who did show an initial response and progressed slower. In fact, this is a potential benefit of this multi-state evidence synthesis method. Separate estimation of transition rates between health states cannot capture this aspect. To capture differential patterns between treatments, a relative treatment effect for the progression-to-death transition can be incorporated in the evidence synthesis model.
                            </p>
                            <p id="p-76">
                             All studies provided PFS and OS Kaplan-Meier data in the example analyses. In principle, the NMA model can be extended to create a shared-parameter model to incorporate studies that only provide information for PFS or only for OS. Studies with only PFS data provide evidence regarding the stable-to-progression and stable-to-death transitions and contribute to estimating the corresponding treatment specific hazard ratios if these are assumed fixed or exchangeable across all studies providing direct or indirect evidence for that particular intervention. (When a meta-analysis of absolute effects with the overall reference treatment is performed, the fixed effects or exchangeability assumption applies to the transition rates.) Incorporating studies that only provide OS data for a particular intervention in the NMA will require the additional assumption of fixed or exchangeable rates for one of the transitions across all studies for that intervention, if treatment is assumed to impact more than just the stable-to-progression transition in order to facilitate parameter estimation. A related topic for future research is whether and how this framework can be used to validate PFS as a surrogate for OS and to predict OS for novel interventions for which only mature PFS is available. This will be of great benefit for cost-effectiveness analyses.
                            </p>
                           </div>
                           <div class="section" id="sec-12">
                            <h2 class="">
                             5 Conclusion
                            </h2>
                            <p id="p-77">
                             We introduced a method for the joint meta-analysis of PFS and OS that is based on a non-homogenous Markovian tri-state transition model. Arbitrary hazard rate functions can be approximated by piecewise constant hazard rates at successive time intervals, and are flexibly modeled as (fractional) polynomial functions of time. The proposed approach relaxes the proportional hazards assumption, extends to a network of more than two treatments, and simplifies the parameterization of decision and cost-effectiveness analyses. The data needed to run these analyses can be extracted directly from published survival curves.
                            </p>
                           </div>
                           <div class="section data-availability" id="sec-13">
                            <h2 class="">
                             Data Availability
                            </h2>
                            <p id="p-78">
                             Dataset is available upon reasonable request.
                            </p>
                           </div>
                           <div class="section" id="sec-14">
                            <h2 class="">
                             6 Conflict of interest
                            </h2>
                            <p id="p-79">
                             The authors have no conflict of interest related to this work to report.
                            </p>
                           </div>
                           <div class="section" id="sec-15">
                            <h2 class="">
                             7 Funding
                            </h2>
                            <p id="p-80">
                             This work was supported by the UCSF Academic Senate Committee on Research (Academic Senate RAP Grant). The funders had no role in the preparation, review, or approval of the manuscript or the decision to submit the manuscript for publication.
                            </p>
                           </div>
                           <div class="section" id="sec-16">
                            <h2 class="">
                             8 Data availability statement
                            </h2>
                            <p id="p-81">
                             The data that support the findings of this study are available from the corresponding author upon reasonable request.
                            </p>
                           </div>
                           <div class="section app" id="app-1">
                            <h2 class="">
                             Appendices
                            </h2>
                            <div class="section" id="sec-17">
                             <h3>
                              A Constructing dataset for analyses
                             </h3>
                             <p id="p-82">
                              Data inputs required are the coordinates extracted from digitally scanned PFS and OS Kaplan-Meier curves: time points (u),corresponding survival probabilities (s
                              <sub>
                               u
                              </sub>
                              ), and corresponding population size at risk (n
                              <sub>
                               u
                              </sub>
                              ). These points must capture all steps in the curve, and may require adjustments to the extracted coordinates to ensure the survival probabilities are decreasing with time. For both curves it should include the times at which numbers at risk are reported below the curve.
                             </p>
                             <p id="p-83">
                              The total follow-up time can be partitioned into M successive non-overlapping intervals indexed by m = 1, …, M. We refer to interval m as U
                              <sub>
                               m
                              </sub>
                              and write u ∈ U
                              <sub>
                               m
                              </sub>
                              to denote u
                              <sub>
                               m
                              </sub>
                              ≤ u < u
                              <sub>
                               m+1
                              </sub>
                              . The length of U
                              <sub>
                               m
                              </sub>
                              is Δu
                              <sub>
                               m
                              </sub>
                              = u
                              <sub>
                               m+1
                              </sub>
                              − u
                              <sub>
                               m
                              </sub>
                              . For each time interval m, we want to obtain four data points: At the beginning of the interval, u
                              <sub>
                               m
                              </sub>
                              ; at 1/3 of the length of the interval,
                              <span class="inline-formula" id="inline-formula-49">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-49.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-49.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , which we define as
                              <span class="inline-formula" id="inline-formula-50">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-50.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-50.gif"/>
                                </noscript>
                               </span>
                              </span>
                              ; at 2/3 of the length of the interval,
                              <span class="inline-formula" id="inline-formula-51">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-51.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-51.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , which we define as
                              <span class="inline-formula" id="inline-formula-52">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-52.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-52.gif"/>
                                </noscript>
                               </span>
                              </span>
                              ; and at the end of the interval, u
                              <sub>
                               m+1
                              </sub>
                              . It is desirable to have the time intervals defined in such a way that (some) of these time points are aligned with the time point for which the size of the at-risk population is reported below the published Kaplan-Meier curves, and are the same for PFS and OS where available. For the current study, we used intervals with a length of three months.
                             </p>
                             <p id="p-84">
                              If no PFS or OS proportion have been recorded for a specific time point of interest (i.e. whole months), a corresponding value for s
                              <sub>
                               u
                              </sub>
                              can be obtained by linear interpolation of the first available extracted scanned survival proportions before and after this time point.
                             </p>
                             <p id="p-85">
                              When the population n
                              <sub>
                               u
                              </sub>
                              is not reported below the PFS and OS Kaplan-Meier curve for certain time points u, it can be imputed. First, based on the reported size of the at-risk population at subsequent time points (n
                              <sub>
                               u+1
                              </sub>
                              ), n
                              <sub>
                               u
                              </sub>
                              will be estimated according to
                              <span class="inline-formula" id="inline-formula-53">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-53.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-53.gif"/>
                                </noscript>
                               </span>
                              </span>
                              . With this ‘backward calculation’ approach we implicitly assume that censoring occurs before the events happen within a time interval. However, this approach is not feasible if there is no information regarding the at-risk population for time intervals beyond the at-risk population reported at a certain time point. In other words, this approach is only feasibly for intervals up to the latest time point for which population is reported. Next, n
                              <sub>
                               u
                              </sub>
                              will be estimated according to
                              <span class="inline-formula" id="inline-formula-54">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-54.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-54.gif"/>
                                </noscript>
                               </span>
                              </span>
                              . The disadvantage of this ‘forward calculation’ approach is that censoring is ignored and the sample size potentially too large for those timepoints. For intervals where both
                              <span class="inline-formula" id="inline-formula-55">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-55.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-55.gif"/>
                                </noscript>
                               </span>
                              </span>
                              and
                              <span class="inline-formula" id="inline-formula-56">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-56.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-56.gif"/>
                                </noscript>
                               </span>
                              </span>
                              was calculated, the actual estimate for the population at-risk is calculated as:
                              <span class="inline-formula" id="inline-formula-57">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-57.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-57.gif"/>
                                </noscript>
                               </span>
                              </span>
                              to ensure the sample size is not overestimated. For time points where
                              <span class="inline-formula" id="inline-formula-58">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-58.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-58.gif"/>
                                </noscript>
                               </span>
                              </span>
                              could not be calculated,
                              <span class="inline-formula" id="inline-formula-59">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-59.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-59.gif"/>
                                </noscript>
                               </span>
                              </span>
                              .
                             </p>
                             <p id="p-86">
                              Based on the subsequent s
                              <sub>
                               u
                              </sub>
                              for the four points at each interval (i.e.
                              <span class="inline-formula" id="inline-formula-60">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-60.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-60.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and
                              <span class="inline-formula" id="inline-formula-61">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-61.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-61.gif"/>
                                </noscript>
                               </span>
                              </span>
                              ) three conditional survival proportions are obtained:
                              <span class="inline-formula" id="inline-formula-62">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-62.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-62.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and
                              <span class="inline-formula" id="inline-formula-63">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-63.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-63.gif"/>
                                </noscript>
                               </span>
                              </span>
                              . The corresponding sample sizes are defined as
                              <span class="inline-formula" id="inline-formula-64">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-64.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-64.gif"/>
                                </noscript>
                               </span>
                              </span>
                              . The corresponding observed number of patients who have not yet experienced progression or death are calculated according to
                              <span class="inline-formula" id="inline-formula-65">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-65.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-65.gif"/>
                                </noscript>
                               </span>
                              </span>
                              .
                             </p>
                             <p id="p-87">
                              Applying this algorithm to PFS and OS of each arm i of each trial k, we get a data set with
                              <span class="inline-formula" id="inline-formula-66">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-66.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-66.gif"/>
                                </noscript>
                               </span>
                              </span>
                              and
                              <span class="inline-formula" id="inline-formula-67">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-67.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-67.gif"/>
                                </noscript>
                               </span>
                              </span>
                              .
                             </p>
                             <p id="p-88">
                              We set-up the event dataset such that every row represents one time interval with
                              <span class="inline-formula" id="inline-formula-68">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-68.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-68.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and
                              <span class="inline-formula" id="inline-formula-69">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-69.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-69.gif"/>
                                </noscript>
                               </span>
                              </span>
                              corresponding to
                              <span class="inline-formula" id="inline-formula-70">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-70.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-70.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and u
                              <sub>
                               m+1
                              </sub>
                              . In addition, each row has a variable related to follow-up time
                              <span class="inline-formula" id="inline-formula-71">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-71.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-71.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , three variables related to
                              <span class="inline-formula" id="inline-formula-72">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-72.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-72.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , and
                              <span class="inline-formula" id="inline-formula-73">
                               <span class="highwire-responsive-lazyload">
                                <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-73.gif"/>
                                <noscript>
                                 <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-73.gif"/>
                                </noscript>
                               </span>
                              </span>
                              , the study number, and study-arm number within that study.
                             </p>
                             <p id="p-89">
                              In additon to the event dataset, we create a study dataset indicating the compared interventions in each study along with the number of study arms.
                             </p>
                            </div>
                            <div class="section" id="sec-18">
                             <h3>
                              B States and between-state transition rates
                             </h3>
                             <div id="sec-19" class="subsection">
                              <h4>
                               B.1 Dynamic transitions - Problem specification
                              </h4>
                              <p id="p-90">
                               <a id="xref-fig-1-2" class="xref-fig" href="#F1">
                                Figure 1
                               </a>
                               represents a closed dynamic system (S
                               <sub>
                                ik
                               </sub>
                               (u) + P
                               <sub>
                                ik
                               </sub>
                               (u) + D
                               <sub>
                                ik
                               </sub>
                               (u) = 1) whose evolution is determined by a known initial condition at time u = 0 and three differential equations:
                               <span class="disp-formula" id="disp-formula-11">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-20.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-20.gif"/>
                                 </noscript>
                                </span>
                               </span>
                               with
                               <span class="inline-formula" id="inline-formula-74">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-74.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-74.gif"/>
                                 </noscript>
                                </span>
                               </span>
                               , and
                               <span class="inline-formula" id="inline-formula-75">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-75.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-75.gif"/>
                                 </noscript>
                                </span>
                               </span>
                               the time-varying hazard rates for the transitions in the figure.
                              </p>
                             </div>
                             <div id="sec-20" class="subsection">
                              <h4>
                               B.2 Aproximating arbitrary
                               <span class="inline-formula" id="inline-formula-76">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-76.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-76.gif"/>
                                 </noscript>
                                </span>
                               </span>
                               , and
                               <span class="inline-formula" id="inline-formula-77">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-77.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/inline-graphic-77.gif"/>
                                 </noscript>
                                </span>
                               </span>
                              </h4>
                              <p id="p-91">
                               We can approximate arbitrary hazard rate functions with a set of discontinuous constant hazard rates over successive time intervals. We prefer this approximation because the system
                               <a id="xref-disp-formula-11-1" class="xref-disp-formula" href="#disp-formula-11">
                                Equation A1
                               </a>
                               can be solved analytically when the transition rates are constant using the the eigenvalue method for first-order differential equations. For u ∈ U
                               <sub>
                                m
                               </sub>
                               <a id="xref-disp-formula-11-2" class="xref-disp-formula" href="#disp-formula-11">
                                Equation A1
                               </a>
                               become:
                               <span class="disp-formula" id="disp-formula-12">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-21.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-21.gif"/>
                                 </noscript>
                                </span>
                               </span>
                              </p>
                             </div>
                             <div id="sec-21" class="subsection">
                              <h4>
                               B.3 Analytic solutions for S
                               <sub>
                                ik
                               </sub>
                               (u), P
                               <sub>
                                ik
                               </sub>
                               (u), and D
                               <sub>
                                ik
                               </sub>
                               (u) where u ∈ U
                               <sub>
                                m
                               </sub>
                              </h4>
                              <p id="p-92">
                               Write the system in
                               <a id="xref-disp-formula-12-1" class="xref-disp-formula" href="#disp-formula-12">
                                Equation A2
                               </a>
                               in matrix form:
                               <span class="disp-formula" id="disp-formula-13">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-22.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-22.gif"/>
                                 </noscript>
                                </span>
                               </span>
                               with the obvious notational correspondence between the two equations. For u ∈ U
                               <sub>
                                m
                               </sub>
                               the system is homogenous and its general solution is the superposition:
                               <span class="disp-formula" id="disp-formula-14">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-23.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-23.gif"/>
                                 </noscript>
                                </span>
                               </span>
                               where λ
                               <sub>
                                1,ik
                               </sub>
                               , λ
                               <sub>
                                2,ik
                               </sub>
                               , and λ
                               <sub>
                                3,ik
                               </sub>
                               are the eigenvalues of the coefficient matrix
                               <strong>
                                A
                               </strong>
                               <sub>
                                ik
                               </sub>
                               .
                               <strong>
                                v
                               </strong>
                               <sub>
                                <strong>
                                 1
                                </strong>
                                ik
                               </sub>
                               ,
                               <strong>
                                v
                               </strong>
                               <sub>
                                <strong>
                                 2
                                </strong>
                                ik
                               </sub>
                               and
                               <strong>
                                v
                               </strong>
                               <sub>
                                <strong>
                                 3
                                </strong>
                                ik
                               </sub>
                               are the corresponding eigenvectors, and c
                               <sub>
                                1,ik
                               </sub>
                               , c
                               <sub>
                                2,ik
                               </sub>
                               , c
                               <sub>
                                3,ik
                               </sub>
                               scalar constants to be identified from the initial condition in
                               <a id="xref-disp-formula-12-2" class="xref-disp-formula" href="#disp-formula-12">
                                Equation A2
                               </a>
                               . In our case:
                               <span class="disp-formula" id="disp-formula-15">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-24.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-24.gif"/>
                                 </noscript>
                                </span>
                               </span>
                               The eigenvectors are:
                               <span class="disp-formula" id="disp-formula-16">
                                <span class="highwire-responsive-lazyload">
                                 <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-25.gif"/>
                                 <noscript>
                                  <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-25.gif"/>
                                 </noscript>
                                </span>
                               </span>
                              </p>
                              <div id="sec-22" class="subsection">
                               <h5>
                                B.3.1 Identification of constants in the general solution
                               </h5>
                               <p id="p-93">
                                The constants c
                                <sub>
                                 1,ik
                                </sub>
                                , c
                                <sub>
                                 2,ik
                                </sub>
                                , c
                                <sub>
                                 3,ik
                                </sub>
                                are identied from the proportions at the beginning of U
                                <sub>
                                 m
                                </sub>
                                . Setting u = u
                                <sub>
                                 m
                                </sub>
                                in the general solution, and using the initial condition in
                                <a id="xref-disp-formula-11-3" class="xref-disp-formula" href="#disp-formula-11">
                                 Equation A1
                                </a>
                                and
                                <a id="xref-disp-formula-12-3" class="xref-disp-formula" href="#disp-formula-12">
                                 Equation A2
                                </a>
                                we obtain:
                                <span class="disp-formula" id="disp-formula-17">
                                 <span class="highwire-responsive-lazyload">
                                  <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-26.gif"/>
                                  <noscript>
                                   <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-26.gif"/>
                                  </noscript>
                                 </span>
                                </span>
                                where v
                                <sub>
                                 xy,ik
                                </sub>
                                is element x of eigenvector y.
                               </p>
                              </div>
                              <div id="sec-23" class="subsection">
                               <h5>
                                B.3.2 Solution for S
                                <sub>
                                 ik
                                </sub>
                                (u), u ∈ U
                                <sub>
                                 m
                                </sub>
                               </h5>
                               <p id="p-94">
                                Substituting c
                                <sub>
                                 1,ik
                                </sub>
                                , c
                                <sub>
                                 2,ik
                                </sub>
                                , c
                                <sub>
                                 3,ik
                                </sub>
                                from
                                <a id="xref-disp-formula-17-1" class="xref-disp-formula" href="#disp-formula-17">
                                 Equation A7
                                </a>
                                in
                                <a id="xref-disp-formula-14-1" class="xref-disp-formula" href="#disp-formula-14">
                                 Equation A4
                                </a>
                                we obtain for S
                                <sub>
                                 ik
                                </sub>
                                (u) :
                                <span class="disp-formula" id="disp-formula-18">
                                 <span class="highwire-responsive-lazyload">
                                  <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-27.gif"/>
                                  <noscript>
                                   <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-27.gif"/>
                                  </noscript>
                                 </span>
                                </span>
                               </p>
                              </div>
                              <div id="sec-24" class="subsection">
                               <h5>
                                B.3.3 Solution for P
                                <sub>
                                 ik
                                </sub>
                                (u), u ∈ U
                                <sub>
                                 m
                                </sub>
                               </h5>
                               <p id="p-95">
                                Substituting c
                                <sub>
                                 1,ik
                                </sub>
                                , c
                                <sub>
                                 2,ik
                                </sub>
                                , c
                                <sub>
                                 3,ik
                                </sub>
                                from
                                <a id="xref-disp-formula-17-2" class="xref-disp-formula" href="#disp-formula-17">
                                 Equation A7
                                </a>
                                in
                                <a id="xref-disp-formula-14-2" class="xref-disp-formula" href="#disp-formula-14">
                                 Equation A4
                                </a>
                                we obtain for P
                                <sub>
                                 ik
                                </sub>
                                (u):
                                <span class="disp-formula" id="disp-formula-19">
                                 <span class="highwire-responsive-lazyload">
                                  <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-28.gif"/>
                                  <noscript>
                                   <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-28.gif"/>
                                  </noscript>
                                 </span>
                                </span>
                               </p>
                              </div>
                              <div id="sec-25" class="subsection">
                               <h5>
                                B.3.4 Solution for D
                                <sub>
                                 ik
                                </sub>
                                (u), u ∈ U
                                <sub>
                                 m
                                </sub>
                               </h5>
                               <p id="p-96">
                                Using
                                <a id="xref-disp-formula-11-4" class="xref-disp-formula" href="#disp-formula-11">
                                 Equation A1
                                </a>
                                ,
                                <a id="xref-disp-formula-18-1" class="xref-disp-formula" href="#disp-formula-18">
                                 Equation A8
                                </a>
                                , and
                                <a id="xref-disp-formula-19-1" class="xref-disp-formula" href="#disp-formula-19">
                                 Equation A9
                                </a>
                                we obtain:
                                <span class="disp-formula" id="disp-formula-20">
                                 <span class="highwire-responsive-lazyload">
                                  <img src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" class="highwire-embed lazyload" alt="Embedded Image" data-src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-29.gif"/>
                                  <noscript>
                                   <img class="highwire-embed" alt="Embedded Image" src="https://www.medrxiv.org/sites/default/files/highwire/medrxiv/early/2022/09/30/2020.11.13.20231332/embed/graphic-29.gif"/>
                                  </noscript>
                                 </span>
                                </span>
                               </p>
                              </div>
                             </div>
                            </div>
                            <div class="section" id="sec-26">
                             <h3>
                              C Online supplement
                             </h3>
                             <div id="sec-27" class="subsection">
                              <h4>
                               C.1 Kaplan-Meier curves
                              </h4>
                              <div id="F7" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F7.large.jpg?width=800&height=600&carousel=1" title="ARCHER-1050, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">ARCHER-1050, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A1:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F7.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A1:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F7.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F7.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A1:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F7.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A1:
                                </span>
                                <span class="caption-title">
                                 ARCHER-1050, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F8" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F8.large.jpg?width=800&height=600&carousel=1" title="LUX-LUNG 7, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">LUX-LUNG 7, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A2:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F8.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A2:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F8.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F8.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A2:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F8.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A2:
                                </span>
                                <span class="caption-title">
                                 LUX-LUNG 7, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F9" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F9.large.jpg?width=800&height=600&carousel=1" title="LUX-LUNG 3, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">LUX-LUNG 3, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A3:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F9.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A3:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F9.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F9.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A3:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F9.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A3:
                                </span>
                                <span class="caption-title">
                                 LUX-LUNG 3, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F10" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F10.large.jpg?width=800&height=600&carousel=1" title="LUX-LUNG 6, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">LUX-LUNG 6, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A4:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F10.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A4:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F10.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F10.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A4:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F10.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A4:
                                </span>
                                <span class="caption-title">
                                 LUX-LUNG 6, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F11" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F11.large.jpg?width=800&height=600&carousel=1" title="EURTAC, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">EURTAC, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A5:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F11.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A5:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F11.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F11.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A5:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F11.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A5:
                                </span>
                                <span class="caption-title">
                                 EURTAC, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F12" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F12.large.jpg?width=800&height=600&carousel=1" title="ENSURE, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">ENSURE, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A6:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F12.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A6:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F12.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F12.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A6:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F12.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A6:
                                </span>
                                <span class="caption-title">
                                 ENSURE, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F13" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F13.large.jpg?width=800&height=600&carousel=1" title="OPTIMAL, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">OPTIMAL, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A7:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F13.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A7:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F13.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F13.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A7:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F13.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A7:
                                </span>
                                <span class="caption-title">
                                 OPTIMAL, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F14" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F14.large.jpg?width=800&height=600&carousel=1" title="FirstSIGNAL, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">FirstSIGNAL, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A8:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F14.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A8:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F14.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F14.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A8:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F14.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A8:
                                </span>
                                <span class="caption-title">
                                 FirstSIGNAL, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F15" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F15.large.jpg?width=800&height=600&carousel=1" title="WJTOG3405, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">WJTOG3405, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A9:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F15.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A9:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F15.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F15.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A9:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F15.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A9:
                                </span>
                                <span class="caption-title">
                                 WJTOG3405, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F16" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F16.large.jpg?width=800&height=600&carousel=1" title="IPASS, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">IPASS, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A10:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F16.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A10:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F16.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F16.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A10:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F16.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A10:
                                </span>
                                <span class="caption-title">
                                 IPASS, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F17" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F17.large.jpg?width=800&height=600&carousel=1" title="NEJ002, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">NEJ002, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A11:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F17.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A11:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F17.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F17.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A11:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F17.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A11:
                                </span>
                                <span class="caption-title">
                                 NEJ002, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F18" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F18.large.jpg?width=800&height=600&carousel=1" title="Han 2017, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Han 2017, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A12:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F18.medium.gif" width="403" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A12:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F18.medium.gif" width="403" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F18.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A12:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F18.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A12:
                                </span>
                                <span class="caption-title">
                                 Han 2017, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F19" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F19.large.jpg?width=800&height=600&carousel=1" title="Yang 2014 and Yang 2016, progression-free survival and overall survival " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Yang 2014 and Yang 2016, progression-free survival and overall survival</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A13:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F19.medium.gif" width="408" height="440"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A13:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F19.medium.gif" width="408" height="440"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F19.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A13:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F19.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A13:
                                </span>
                                <span class="caption-title">
                                 Yang 2014 and Yang 2016, progression-free survival and overall survival
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                             </div>
                             <div id="sec-28" class="subsection">
                              <h4>
                               C.2 JAGS code random effects NMA model
                              </h4>
                              <p id="p-97">
                               Example JAGS code corresponding to model SP Weibull RE2; SD exponential; PD Weibull FE1(scale) has been presented here.
                              </p>
                              <span class="preformat dialog">
                               model{
# Likelihood for conditional survival probabilities
for (j in 1:Nd){
  r_cond_pfs1[j]∼dbinom(cond_pfs[j,1], n_cond_pfs1[j])
  r_cond_pfs2[j]∼dbinom(cond_pfs[j,2], n_cond_pfs2[j])
  r_cond_pfs3[j]∼dbinom(cond_pfs[j,3], n_cond_pfs3[j])
  r_cond_os1[j]∼dbinom(cond_os[j,1], n_cond_os1[j])
  r_cond_os2[j]∼dbinom(cond_os[j,2], n_cond_os2[j])
  r_cond_os3[j]∼dbinom(cond_os[j,3], n_cond_os3[j])
}
# transformation of conditional survival probabilities to survival probabilities
p4[1]<-1
p5[1]<-0
for (j in 2:Nd){
  p4[j]<-equals(a[j]-a[j-1],0)*p[(j-1),4] + (1-equals(a[j]-a[j-1],0))*1
  p5[j]<-equals(a[j]-a[j-1],0)*p[(j-1),5] + (1-equals(a[j]-a[j-1],0))*0
}
for (j in 1:Nd){
  cond_pfs[j,1]<-p[j,1]/p4[j]
  cond_pfs[j,2]<-p[j,4]/p4[j]
  cond_pfs[j,3]<-p[j,7]/p4[j]
  cond_os[j,1]<-(p[j,1]+p[j,2])/(p4[j]+p5[j])
  cond_os[j,2]<-(p[j,4]+p[j,5])/(p4[j]+p5[j])
  cond_os[j,3]<-(p[j,7]+p[j,8])/(p4[j]+p5[j])
  # transformation of survival probabilities in time-varying hazards
  # for transitions between health states
  p[j,1]<- p4[j]*exp(-(h.sd[j]+h.sp[j])*dt[j,1])
  p[j,2]<- p5[j]*exp(-h.pd[j]*dt[j,1])+p4[j]*h.sp[j]*(exp(-(h.sd[j]+h.sp[j])*dt[j,1])
        -exp(-h.pd[j]*dt[j,1]))/(h.pd[j]-h.sp[j]-h.sd[j])
  p[j,3]<-1-(p[j,1]+p[j,2])
  p[j,4]<- p4[j]*exp(-(h.sd[j]+h.sp[j])*dt[j,2])
  p[j,5]<- p5[j]*exp(-h.pd[j]*dt[j,2])+p4[j]*h.sp[j]*(exp(-(h.sd[j]+h.sp[j])*dt[j,2])
        -exp(-h.pd[j]*dt[j,2]))/(h.pd[j]-h.sp[j]-h.sd[j])
  p[j,6]<-1-(p[j,4]+p[j,5])
  p[j,7]<- p4[j]*exp(-(h.sd[j]+h.sp[j])*dt[j,3])
  p[j,8]<- p5[j]*exp(-h.pd[j]*dt[j,3])+p4[j]*h.sp[j]*(exp(-(h.sd[j]+h.sp[j])*dt[j,3])
        -exp(-h.pd[j]*dt[j,3]))/(h.pd[j]-h.sp[j]-h.sd[j])
  p[j,9]<-1-(p[j,7]+p[j,8])
  # constraint to avoid “closing off” SD or PD path
  constraint.sd[j] ∼ dinterval(h.sd[j], EPSILON[1]) # h.sd[j] > EPSILON[1] (e.g. >0.001)
  constraint.pd[j] ∼ dinterval(h.pd[j], EPSILON[2]) # h.pd[j] > EPSILON[2] (e.g. >0.001)
  # decribe hazards as a function of time
  log(h.sp[j])<- alpha[s[j],a[j],1]+alpha[s[j],a[j],2]*timetrans1[j]
  log(h.sd[j])<- alpha[s[j],a[j],3]
  log(h.pd[j])<- alpha[s[j],a[j],4]+alpha[s[j],a[j],5]*timetrans1[j]
}
# random effects model
for (i in 1:Ns){
  for (k in 1:na[i]){
    alpha[i,k,1]<-mu[i,1]+delta[i,k]
    alpha[i,k,2]<-mu[i,2]+d[t[i,k],2]-d[t[i,1],2]
    alpha[i,k,3]<-mu[i,3]
    alpha[i,k,4]<-mu[i,4]+d[t[i,k],3]-d[t[i,1],3]
    alpha[i,k,5]<-mu[i,5]
}
w[i,1]<-0
delta[i,1]<-0
for (k in 2:na[i]){
  delta[i,k]∼dnorm(md[i,k],taud[i,k])
  md[i,k]<-d[t[i,k],1]-d[t[i,1],1] +sw[i,k]
  w[i,k] <- (delta[i,k] - d[t[i,k],1] + d[t[i,1],1])
  sw[i,k] <- sum(w[i,1:(k-1)])/(k-1)
  taud[i,k] <- tau *2*(k-1)/k
}
}
# priors
for (i in 1:Ns){
mu[i,1:5] ∼ dmnorm(prior_mean_mu[1:5],prior_varcov_mu[,])
}
d[1,1]<-0
d[1,2]<-0
d[1,3]<-0
for (T in 2:Nt){
d[T,1:3] ∼ dmnorm(prior_mean_d[1:3],prior_varcov_d[,])
}
sd∼dunif(0,2)
tau<-1/(sd*sd)
# output
for (T in 2:Nt){
for (u in 1:48){
  log(HR.SP[1,T,u])<-(d[T,1]-d[1,1])+(d[T,2]-d[1,2])*log(u)
  log(HR.SD[1,T,u])<-0
  log(HR.PD[1,T,u])<-(d[T,3]-d[1,3])
}
}
Mu_mean[1]<- -3.563312141
Mu_mean[2]<- 0.486802196
Mu_mean[3]<- -4.580999291
Mu_mean[4]<- -3.488028822
Mu_mean[5]<- 0.174942184
for (T in 1:Nt){
Alpha1[T]<-Mu_mean[1]+d[T,1]
Alpha2[T]<-Mu_mean[2]+d[T,2]
Alpha3[T]<-Mu_mean[3]
Alpha4[T]<-Mu_mean[4]+d[T,3]
Alpha5[T]<-Mu_mean[5]
}
for (T in 1:Nt){
for (u in 1:48){
  log(HAZARD.SP[T,u])<-(Alpha1[T])+(Alpha2[T])*log(u)
  log(HAZARD.SD[T,u])<-(Alpha3[T])
  log(HAZARD.PD[T,u])<-(Alpha4[T])+(Alpha5[T])*log(u)
}}
for (T in 1:Nt){
P.S[T,1]<-1*exp(-(HAZARD.SD[T,1]+HAZARD.SP[T,1]))
P.P[T,1]<-0*exp(-HAZARD.PD[T,1])+1*HAZARD.SP[T,1]*(exp(-(HAZARD.SD[T,1]+HAZARD.SP[T,1]))
        -exp(-HAZARD.PD[T,1]))/(HAZARD.PD[T,1]-HAZARD.SP[T,1]-HAZARD.SD[T,1])
PFS[T,1]<-P.S[T,1]
OS[T,1]<-P.S[T,1]+P.P[T,1]
for (u in 2:48){
  P.S[T,u]<-P.S[T,(u-1)]*exp(-(HAZARD.SD[T,u]+HAZARD.SP[T,u]))
  P.P[T,u]<-P.P[T,(u-1)]*exp(-HAZARD.PD[T,u])+P.S[T,(u-1)]*HAZARD.SP[T,u]
        *(exp(-(HAZARD.SD[T,u]+HAZARD.SP[T,u]))
        -exp(-HAZARD.PD[T,u]))/(HAZARD.PD[T,u]-HAZARD.SP[T,u]-HAZARD.SD[T,u])
  PFS[T,u]<-P.S[T,u]
  OS[T,u]<-P.S[T,u]+P.P[T,u]
  }
}
}
                              </span>
                             </div>
                             <div id="sec-29" class="subsection">
                              <h4>
                               C.3 Simulation to assess performance of estimating stable-to-progression, stable-to-death, and progression-to-death hazard rates simultaneously based on conditional PFS and OS data for a given time interval
                              </h4>
                              <p id="p-98">
                               In order to assess the performance of estimating interval specific hazard rates for the stable-to-progression, stable-to-death, and progression-to-death transitions based on conditional PFS and OS data with the approach as proposed in this paper, we performed a simple simulation study for a single time interval. We set true values for each of the three transitions as follows: h
                               <sup>
                                SP
                               </sup>
                               = {0.1, 0.2, 0.3, 0.4, 0.5}, h
                               <sup>
                                SD
                               </sup>
                               = {0.02, 0.05, 0.1}, and h
                               <sup>
                                SP
                               </sup>
                               = {0.05, 0.1, 0.15, 0.2, 0.25}. The sample size was assumed to be 1000. Based on the true rates and sample size, the number of PFS and OS events for four timepoints over a 3-month time interval were determined and subsequently transformed in three conditional PFS events and three conditional OS events according the approach described in the Appendix. This data was used to estimate h
                               <sup>
                                SP
                               </sup>
                               , h
                               <sup>
                                SD
                               </sup>
                               , and h
                               <sup>
                                P D
                               </sup>
                               according to
                               <a id="xref-disp-formula-4-4" class="xref-disp-formula" href="#disp-formula-4">
                                Equation 4
                               </a>
                               ,
                               <a id="xref-disp-formula-5-4" class="xref-disp-formula" href="#disp-formula-5">
                                Equation 5
                               </a>
                               , and
                               <a id="xref-disp-formula-6-4" class="xref-disp-formula" href="#disp-formula-6">
                                Equation 6
                               </a>
                               for each simulation run. One hundred simulation runs were performed for each scenario.
                              </p>
                              <p id="p-99">
                               Results are presented in
                               <a id="xref-table-wrap-4-1" class="xref-table" href="#T4">
                                Table A1
                               </a>
                               ,
                               <a id="xref-fig-20-1" class="xref-fig" href="#F20">
                                Figure A14
                               </a>
                               ,
                               <a id="xref-fig-21-1" class="xref-fig" href="#F21">
                                Figure A15
                               </a>
                               , and
                               <a id="xref-fig-22-1" class="xref-fig" href="#F22">
                                Figure A16
                               </a>
                               . The mean of the estimates for h
                               <sup>
                                SP
                               </sup>
                               , h
                               <sup>
                                SD
                               </sup>
                               , and h
                               <sup>
                                P D
                               </sup>
                               across the hundred simulaton runs are close to the true hazard rates. The mean of the standard deviation of the posterior distribution for log(h
                               <sup>
                                SP
                               </sup>
                               ) (equivalent to the mean of the standard error of the estimate with a frequentist analysis) across the hundred simulaton runs and the standard deviation of the estimates for log(h
                               <sup>
                                SP
                               </sup>
                               ) across the same simulation runs were relatively similar across the different scenarios. However, for h
                               <sup>
                                SD
                               </sup>
                               , and expecially for h
                               <sup>
                                P D
                               </sup>
                               , the mean standard deviation of the posterior distribution is larger than the standard deviation of the estimates indicating that the obtained 95% credible intervals for these transitions with the proposed approach seem conservative. The proportion of 95% credible intervals that include the true hazard rate over the hundred simulation-runs is about 95% for h
                               <sup>
                                SP
                               </sup>
                               but may be higher or less than 90% depending on the true rate of each of the three transitions as depicted in
                               <a id="xref-fig-20-2" class="xref-fig" href="#F20">
                                Figure A14
                               </a>
                               . For h
                               <sup>
                                SD
                               </sup>
                               and h
                               <sup>
                                P D
                               </sup>
                               , the proportion of 95% credible intervals that include the true hazard rates over the hundred simulation runs seems greater than 95%, indiciting some degree of overcoverage.
                              </p>
                              <div id="T4" class="table pos-float">
                               <div class="table-inline table-callout-links">
                                <div class="callout">
                                 <span>
                                  View this table:
                                 </span>
                                 <ul class="callout-links">
                                  <li class="view-inline first">
                                   <a href="##" class="table-expand-inline" data-table-url="/highwire/markup/566962/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&table-expand-inline=1" data-icon-position="" data-hide-link-title="0">
                                    View inline
                                   </a>
                                  </li>
                                  <li class="view-popup">
                                   <a href="/highwire/markup/566962/expansion?width=1000&height=500&iframe=true&postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">
                                    View popup
                                   </a>
                                  </li>
                                  <li class="download-ppt last">
                                   <a href="/highwire/powerpoint/566962" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">
                                    Download powerpoint
                                   </a>
                                  </li>
                                 </ul>
                                </div>
                               </div>
                               <div class="table-caption">
                                <span class="table-label">
                                 Table A1:
                                </span>
                                <span class="caption-title">
                                 Performance of estimating simultaneously hazard rates for stable-to-progression, stable-to-death, and progression-to-death transitions based on conditional PFS and OS data for a given time-interval
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F20" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F20.large.jpg?width=800&height=600&carousel=1" title="Coverage probablity of the 95% credible interval of the stable-to-progression hazard rate stratified by progression-to-death and stable-to-death rates " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Coverage probablity of the 95% credible interval of the stable-to-progression hazard rate stratified by progression-to-death and stable-to-death rates</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A14:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F20.medium.gif" width="440" height="417"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A14:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F20.medium.gif" width="440" height="417"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F20.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A14:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F20.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A14:
                                </span>
                                <span class="caption-title">
                                 Coverage probablity of the 95% credible interval of the stable-to-progression hazard rate stratified by progression-to-death and stable-to-death rates
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F21" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F21.large.jpg?width=800&height=600&carousel=1" title="Coverage probablity of the 95% credible interval of the stable-to-death hazard rate stratified by stable-to-progression and progression-to-death rates " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Coverage probablity of the 95% credible interval of the stable-to-death hazard rate stratified by stable-to-progression and progression-to-death rates</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A15:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F21.medium.gif" width="440" height="417"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A15:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F21.medium.gif" width="440" height="417"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F21.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A15:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F21.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A15:
                                </span>
                                <span class="caption-title">
                                 Coverage probablity of the 95% credible interval of the stable-to-death hazard rate stratified by stable-to-progression and progression-to-death rates
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                              <div id="F22" class="fig pos-float type-figure odd">
                               <div class="highwire-figure">
                                <div class="fig-inline-img-wrapper">
                                 <div class="fig-inline-img">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F22.large.jpg?width=800&height=600&carousel=1" title="Coverage probablity of the 95% credible interval of the progression-to-death hazard rate stratified by stable-to-progression and stable-to-death rates " class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-1851738875" data-figure-caption='<div class="highwire-markup"><span xmlns="http://www.w3.org/1999/xhtml" class="caption-title">Coverage probablity of the 95% credible interval of the progression-to-death hazard rate stratified by stable-to-progression and stable-to-death rates</span> </div>' data-icon-position="" data-hide-link-title="0">
                                   <span class="hw-responsive-img">
                                    <img class="highwire-fragment fragment-image lazyload" alt="Figure A16:" src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F22.medium.gif" width="440" height="417"/>
                                    <noscript>
                                     <img class="highwire-fragment fragment-image" alt="Figure A16:" src="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F22.medium.gif" width="440" height="417"/>
                                    </noscript>
                                   </span>
                                  </a>
                                 </div>
                                </div>
                                <ul class="highwire-figure-links inline">
                                 <li class="download-fig first">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F22.large.jpg?download=true" class="highwire-figure-link highwire-figure-link-download" title="Download Figure A16:" data-icon-position="" data-hide-link-title="0">
                                   Download figure
                                  </a>
                                 </li>
                                 <li class="new-tab last">
                                  <a href="https://www.medrxiv.org/content/medrxiv/early/2022/09/30/2020.11.13.20231332/F22.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">
                                   Open in new tab
                                  </a>
                                 </li>
                                </ul>
                               </div>
                               <div class="fig-caption">
                                <span class="fig-label">
                                 Figure A16:
                                </span>
                                <span class="caption-title">
                                 Coverage probablity of the 95% credible interval of the progression-to-death hazard rate stratified by stable-to-progression and stable-to-death rates
                                </span>
                                <div class="sb-div caption-clear">
                                </div>
                               </div>
                              </div>
                             </div>
                            </div>
                           </div>
                           <div class="section fn-group" id="fn-group-1">
                            <h2>
                             Footnotes
                            </h2>
                            <ul>
                             <li class="fn-update fn-group-summary-of-updates" id="fn-1">
                              <p id="p-15">
                               Section 2.2 updated: Used three (rather than two) conditional PFS and OS data points per time interval;
Section 3.4 and Section C2 updated: Tweaked the jags code to improve estimation.
Section C3: Added simple simulation study to assess performance of estimating stable-to-progression, stable-to-death, and progression-to-death hazard rates simultaneously based on conditional PFS and OS data for a given time interval
                              </p>
                             </li>
                            </ul>
                           </div>
                           <div class="section ref-list" id="ref-list-1">
                            <h2 class="">
                             References
                            </h2>
                            <ol class="cit-list ref-use-labels">
                             <li>
                              <span class="ref-label">
                               [1].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference [1] in text" id="ref-1">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.1">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Dias
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jansen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JP
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Sutton
                                  </span>
                                  <span class="cit-name-given-names">
                                   AJ
                                  </span>
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Generalised linear models in Network meta-analysis for decision-making:93-153John Wiley & Sons, Ltd
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [2].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference [2] in text" id="ref-2">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.2">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   West
                                  </span>
                                  <span class="cit-name-given-names">
                                   H
                                  </span>
                                 </span>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Dahlberg
                                  </span>
                                  <span class="cit-name-given-names">
                                   S..
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Clinical Trials, End Points, and Statistics â Measuring and Comparing Cancer Treatments in Practice
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  JAMA Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  4
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1798
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DJAMA%2BOncology%26rft.volume%253D4%26rft.spage%253D1798%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [3].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference [3] in text" id="ref-3">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.3">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Dias
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jansen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JP
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Sutton
                                  </span>
                                  <span class="cit-name-given-names">
                                   AJ
                                  </span>
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  Network meta-analysis of survival outcomes in Network meta-analysis for decision-making:293-322John Wiley & Sons, Ltd
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [4].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference [4] in text" id="ref-4">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.4">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ouwens
                                  </span>
                                  <span class="cit-name-given-names">
                                   MJNM
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Philips
                                  </span>
                                  <span class="cit-name-given-names">
                                   Z
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jansen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JP
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Network meta-analysis of parametric survival curves
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Research Synthesis Methods
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2010
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  1
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  258
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  271
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DResearch%2BSynthesis%2BMethods%26rft.volume%253D1%26rft.spage%253D258%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [5].
                              </span>
                              <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.11.13.20231332v3.5">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jansen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JP
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Network meta-analysis of survival data with fractional polynomials
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  BMC Medical Research Methodology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2011
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  11
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  14
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DBMC%2BMedical%2BResearch%2BMethodology%26rft.volume%253D11%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [6].
                              </span>
                              <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.11.13.20231332v3.6">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jansen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JP
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Cope
                                  </span>
                                  <span class="cit-name-given-names">
                                   S.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Meta-regression models to address heterogeneity and inconsistency in net-work meta-analysis of survival outcomes
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  BMC Medical Research Methodology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2012
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  12
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  16
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DBMC%2BMedical%2BResearch%2BMethodology%26rft.volume%253D12%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [7].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference [7] in text" id="ref-7">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.7">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Cope
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chan
                                  </span>
                                  <span class="cit-name-given-names">
                                   K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jansen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JP
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Multivariate network meta-analysis of survival function parameters
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Research Synthesis Methods
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2020
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  11
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  443
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  456
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DResearch%2BSynthesis%2BMethods%26rft.volume%253D11%26rft.spage%253D443%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [8].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference [8] in text" id="ref-8">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-web" id="cit-2020.11.13.20231332v3.8">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Woods
                                  </span>
                                  <span class="cit-name-given-names">
                                   B
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Sideris
                                  </span>
                                  <span class="cit-name-given-names">
                                   E
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Palmer
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Latimer
                                  </span>
                                  <span class="cit-name-given-names">
                                   N
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Soares
                                  </span>
                                  <span class="cit-name-given-names">
                                   M.
                                  </span>
                                 </span>
                                 <span class="cit-source">
                                  NICE DSU technical support document 19. Partitioned survival analysis for decision modelling in health care: a critical review. 2017
                                 </span>
                                 Available from:
                                 <a href="http://www..nicedsu.org.uk/wp-content/uploads/2017/06/Partitioned-Survival-Analysisfinal-report.pdf">
                                  www..nicedsu.org.uk/wp-content/uploads/2017/06/Partitioned-Survival-Analysisfinal-report.pdf
                                 </a>
                                 .
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [9].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference [9] in text" id="ref-9">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.9" data-doi="10.1002/sim.2712">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Putter
                                  </span>
                                  <span class="cit-name-given-names">
                                   H
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Fiocco
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Geskus
                                  </span>
                                  <span class="cit-name-given-names">
                                   RB
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Tutorial in biostatistics: competing risks and multi-state models
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Statistics in Medicine
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2007
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  26
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  2389
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  2430
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DPutter%26rft.auinit1%253DH.%26rft.volume%253D26%26rft.issue%253D11%26rft.spage%253D2389%26rft.epage%253D2430%26rft.atitle%253DTutorial%2Bin%2Bbiostatistics%253A%2Bcompeting%2Brisks%2Band%2Bmulti-state%2Bmodels.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.2712%26rft_id%253Dinfo%253Apmid%252F17031868%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1002/sim.2712&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=17031868&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000246161400007&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [10].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference [10] in text" id="ref-10">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.10">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Guyot
                                  </span>
                                  <span class="cit-name-given-names">
                                   P
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ouwens
                                  </span>
                                  <span class="cit-name-given-names">
                                   MJNM
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  BMC Medical Research Methodology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2012
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  12
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  13
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DBMC%2BMedical%2BResearch%2BMethodology%26rft.volume%253D12%26rft.spage%253D1%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [11].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference [11] in text" id="ref-11">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.11" data-doi="10.1177/0272989X05282637">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Estimation of Markov chain transition probabilities and rates from fully and partially observed data: uncertainty propagation, evidence synthesis, and model calibration
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Medical Decision Making
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2005
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  25
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  633
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  645
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DMedical%2BDecision%2BMaking%26rft.stitle%253DMed%2BDecis%2BMaking%26rft.aulast%253DWelton%26rft.auinit1%253DN.%2BJ.%26rft.volume%253D25%26rft.issue%253D6%26rft.spage%253D633%26rft.epage%253D645%26rft.atitle%253DEstimation%2Bof%2BMarkov%2BChain%2BTransition%2BProbabilities%2Band%2BRates%2Bfrom%2BFully%2Band%2BPartially%2BObserved%2BData%253A%2BUncertainty%2BPropagation%252C%2BEvidence%2BSynthesis%252C%2Band%2BModel%2BCalibration%26rft_id%253Dinfo%253Adoi%252F10.1177%252F0272989X05282637%26rft_id%253Dinfo%253Apmid%252F16282214%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1177/0272989X05282637&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=16282214&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000233338300006&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [12].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference [12] in text" id="ref-12">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.12" data-doi="10.1002/sim.4059">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Price
                                  </span>
                                  <span class="cit-name-given-names">
                                   MJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Parameterization of treatment effects for meta-analysis in multi-state Markov models
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Statistics in Medicine
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2011
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  30
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  140
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  151
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DPrice%26rft.auinit1%253DM.%2BJ.%26rft.volume%253D30%26rft.issue%253D2%26rft.spage%253D140%26rft.epage%253D151%26rft.atitle%253DParameterization%2Bof%2Btreatment%2Beffects%2Bfor%2Bmeta-analysis%2Bin%2Bmulti-state%2BMarkov%2Bmodels.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.4059%26rft_id%253Dinfo%253Apmid%252F20963750%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1002/sim.4059&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=20963750&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [13].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference [13] in text" id="ref-13">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.13">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Mavranezouli
                                  </span>
                                  <span class="cit-name-given-names">
                                   I
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Dias
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Whittington
                                  </span>
                                  <span class="cit-name-given-names">
                                   C
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Kendall
                                  </span>
                                  <span class="cit-name-given-names">
                                   T.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Network meta-analysis with competing risk outcomes
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Value in Health
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2010
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  13
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  976
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  983
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DValue%2Bin%2BHealth%26rft.volume%253D13%26rft.spage%253D976%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [14].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference [14] in text" id="ref-14">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.14" data-doi="10.1002/sim.3594">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Cooper
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Sutton
                                  </span>
                                  <span class="cit-name-given-names">
                                   AJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Morris
                                  </span>
                                  <span class="cit-name-given-names">
                                   D
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Statistics in Medicine
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2009
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  28
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1861
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1881
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DStatistics%2Bin%2Bmedicine%26rft.stitle%253DStat%2BMed%26rft.aulast%253DCooper%26rft.auinit1%253DN.%2BJ.%26rft.volume%253D28%26rft.issue%253D14%26rft.spage%253D1861%26rft.epage%253D1881%26rft.atitle%253DAddressing%2Bbetween-study%2Bheterogeneity%2Band%2Binconsistency%2Bin%2Bmixed%2Btreatment%2Bcomparisons%253A%2BApplication%2Bto%2Bstroke%2Bprevention%2Btreatments%2Bin%2Bindividuals%2Bwith%2Bnon-rheumatic%2Batrial%2Bfibrillation.%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fsim.3594%26rft_id%253Dinfo%253Apmid%252F19399825%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1002/sim.3594&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=19399825&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000267083100001&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [15].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference [15] in text" id="ref-15">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.15" data-doi="10.1016/S1470-2045(17)30608-3">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-given-names">
                                   Wu
                                  </span>
                                  <span class="cit-name-surname">
                                   Ylong
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Cheng
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Zhou
                                  </span>
                                  <span class="cit-name-given-names">
                                   X
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Dacomitinib versus gefitinib as first-line treatment for patients with EGFR-mutation-positive non-small-cell lung cancer (ARCHER 1050): a randomised, open-label, phase 3 trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2017
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  18
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1454
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1466
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DThe%2BLancet%2BOncology%26rft.volume%253D18%26rft.spage%253D1454%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1470-2045%252817%252930608-3%26rft_id%253Dinfo%253Apmid%252F28958502%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S1470-2045(17)30608-3&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=28958502&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [16].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference [16] in text" id="ref-16">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.16">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Mok
                                  </span>
                                  <span class="cit-name-given-names">
                                   TS
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Cheng
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Zhou
                                  </span>
                                  <span class="cit-name-given-names">
                                   X
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Improvement in Overall Survival in a Randomized Study That Compared Dacomitinib With Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer and EGFR-Activating Mutations
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Journal of Clinical Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 :JCO–2018.
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [17].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference [17] in text" id="ref-17">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.17" data-doi="10.1016/S1470-2045(16)30033-X">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Park
                                  </span>
                                  <span class="cit-name-given-names">
                                   K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Tan
                                  </span>
                                  <span class="cit-name-given-names">
                                   E-H
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   O’Byrne
                                  </span>
                                  <span class="cit-name-given-names">
                                   K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, openlabel, randomised controlled trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2016
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  17
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  577
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  589
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DThe%2BLancet%2BOncology%26rft.volume%253D17%26rft.spage%253D577%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1470-2045%252816%252930033-X%26rft_id%253Dinfo%253Apmid%252F27083334%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S1470-2045(16)30033-X&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=27083334&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [18].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference [18] in text" id="ref-18">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.18" data-doi="10.1093/annonc/mdw611">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Paz-Ares
                                  </span>
                                  <span class="cit-name-given-names">
                                   L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Tan
                                  </span>
                                  <span class="cit-name-given-names">
                                   E-H
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   O’byrne
                                  </span>
                                  <span class="cit-name-given-names">
                                   K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Annals of Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2017
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  28
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  270
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  277
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DAnnals%2Bof%2BOncology%26rft.volume%253D28%26rft.spage%253D270%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fannonc%252Fmdw611%26rft_id%253Dinfo%253Apmid%252F28426106%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1093/annonc/mdw611&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=28426106&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [19].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference [19] in text" id="ref-19">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.19" data-doi="10.1200/JCO.2012.44.2806">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Sequist
                                  </span>
                                  <span class="cit-name-given-names">
                                   LV
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Yang
                                  </span>
                                  <span class="cit-name-given-names">
                                   JC-H
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Yamamoto
                                  </span>
                                  <span class="cit-name-given-names">
                                   N
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Phase III study of afatinib or cisplatin plus pemetrexed in patients with metastatic lung adenocarcinoma with EGFR mutations
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Journal of Clinical Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2013
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  31
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  3327
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  3334
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BOncology%26rft_id%253Dinfo%253Adoi%252F10.1200%252FJCO.2012.44.2806%26rft_id%253Dinfo%253Apmid%252F23816960%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamNvIjtzOjU6InJlc2lkIjtzOjEwOiIzMS8yNy8zMzI3IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMDkvMzAvMjAyMC4xMS4xMy4yMDIzMTMzMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
                                 <span>
                                  <span class="cit-reflinks-abstract">
                                   Abstract
                                  </span>
                                  <span class="cit-sep cit-reflinks-variant-name-sep">
                                   /
                                  </span>
                                  <span class="cit-reflinks-full-text">
                                   <span class="free-full-text">
                                    FREE
                                   </span>
                                   Full Text
                                  </span>
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [20].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference [20] in text" id="ref-20">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.20" data-doi="10.1016/S1470-2045(14)71173-8">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Yang
                                  </span>
                                  <span class="cit-name-given-names">
                                   JC-H
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Wu
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y-L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Schuler
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Afatinib versus cisplatin-based chemotherapy for EGFR mutation-positive lung adenocarcinoma (LUX-Lung 3 and LUX-Lung 6): analysis of overall survival data from two randomised, phase 3 trials
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2015
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  16
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  141
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  151
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DThe%2BLancet%2BOncology%26rft.volume%253D16%26rft.spage%253D141%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1470-2045%252814%252971173-8%26rft_id%253Dinfo%253Apmid%252F25589191%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S1470-2045(14)71173-8&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=25589191&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [21].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference [21] in text" id="ref-21">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.21" data-doi="10.1016/S1470-2045(13)70604-1">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Wu
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y-L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Zhou
                                  </span>
                                  <span class="cit-name-given-names">
                                   C
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Hu
                                  </span>
                                  <span class="cit-name-given-names">
                                   C-P
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2014
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  15
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  213
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  222
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DThe%2BLancet%2BOncology%26rft.volume%253D15%26rft.spage%253D213%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1470-2045%252813%252970604-1%26rft_id%253Dinfo%253Apmid%252F24439929%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S1470-2045(13)70604-1&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=24439929&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000330228700034&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [22].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference [22] in text" id="ref-22">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.22">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Costa
                                  </span>
                                  <span class="cit-name-given-names">
                                   C
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Molina-Vila
                                  </span>
                                  <span class="cit-name-given-names">
                                   MA
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Drozdowskyj
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  The impact of EGFR T790M mutations and BIM mRNA expression on outcome in patients with EGFR-mutant NSCLC treated with erlotinib or chemotherapy in the randomized phase III EURTAC trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Clinical Cancer Research
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2014
                                 </span>
                                 :clincanres–2233.
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [23].
                              </span>
                              <div class="cit ref-cit ref-journal no-rev-xref" id="cit-2020.11.13.20231332v3.23">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   De Marinis
                                  </span>
                                  <span class="cit-name-given-names">
                                   F
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Vergnenegre
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Passaro
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Erlotinib-associated rash in patients with EGFR mutation-positive non-small-cell lung cancer treated in the EURTAC trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Future Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2015
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  11
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  421
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  429
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DFuture%2BOncology%26rft.volume%253D11%26rft.spage%253D421%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [24].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference [24] in text" id="ref-24">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.24" data-doi="10.1016/S1470-2045(11)70393-X">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Rosell
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Carcereny
                                  </span>
                                  <span class="cit-name-given-names">
                                   E
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Gervais
                                  </span>
                                  <span class="cit-name-given-names">
                                   R
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2012
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  13
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  239
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  246
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DThe%2Blancet%2Boncology%26rft.stitle%253DLancet%2BOncol%26rft.aulast%253DRosell%26rft.auinit1%253DR.%26rft.volume%253D13%26rft.issue%253D3%26rft.spage%253D239%26rft.epage%253D246%26rft.atitle%253DErlotinib%2Bversus%2Bstandard%2Bchemotherapy%2Bas%2Bfirst-line%2Btreatment%2Bfor%2BEuropean%2Bpatients%2Bwith%2Badvanced%2BEGFR%2Bmutation-positive%2Bnon-small-cell%2Blung%2Bcancer%2B%2528EURTAC%2529%253A%2Ba%2Bmulticentre%252C%2Bopen-label%252C%2Brandomised%2Bphase%2B3%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1470-2045%252811%252970393-X%26rft_id%253Dinfo%253Apmid%252F22285168%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S1470-2045(11)70393-X&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=22285168&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000300880600031&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [25].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference [25] in text" id="ref-25">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.25" data-doi="10.1093/annonc/mdv270">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Wu
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y-L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Zhou
                                  </span>
                                  <span class="cit-name-given-names">
                                   C
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Liam
                                  </span>
                                  <span class="cit-name-given-names">
                                   C-K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label, ENSURE study
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Annals of Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2015
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  26
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1883
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1889
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DAnnals%2Bof%2BOncology%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fannonc%252Fmdv270%26rft_id%253Dinfo%253Apmid%252F26105600%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1093/annonc/mdv270&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=26105600&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [26].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference [26] in text" id="ref-26">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.26" data-doi="10.1016/S1470-2045(11)70184-X">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Zhou
                                  </span>
                                  <span class="cit-name-given-names">
                                   C
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Wu
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y-L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chen
                                  </span>
                                  <span class="cit-name-given-names">
                                   G
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2011
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  12
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  735
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  742
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DThe%2Blancet%2Boncology%26rft.stitle%253DLancet%2BOncol%26rft.aulast%253DZhou%26rft.auinit1%253DC.%26rft.volume%253D12%26rft.issue%253D8%26rft.spage%253D735%26rft.epage%253D742%26rft.atitle%253DErlotinib%2Bversus%2Bchemotherapy%2Bas%2Bfirst-line%2Btreatment%2Bfor%2Bpatients%2Bwith%2Badvanced%2BEGFR%2Bmutation-positive%2Bnon-small-cell%2Blung%2Bcancer%2B%2528OPTIMAL%252C%2BCTONG-0802%2529%253A%2Ba%2Bmulticentre%252C%2Bopen-label%252C%2Brandomised%252C%2Bphase%2B3%2Bstudy.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1470-2045%252811%252970184-X%26rft_id%253Dinfo%253Apmid%252F21783417%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S1470-2045(11)70184-X&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=21783417&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000293272100024&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [27].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference [27] in text" id="ref-27">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.27" data-doi="10.1093/annonc/mdv276">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Zhou
                                  </span>
                                  <span class="cit-name-given-names">
                                   C
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Wu
                                  </span>
                                  <span class="cit-name-given-names">
                                   YL
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chen
                                  </span>
                                  <span class="cit-name-given-names">
                                   G
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Annals of Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2015
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  26
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1877
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1883
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DAnnals%2Bof%2BOncology%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fannonc%252Fmdv276%26rft_id%253Dinfo%253Apmid%252F26141208%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1093/annonc/mdv276&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=26141208&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [28].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference [28] in text" id="ref-28">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.28" data-doi="10.1200/JCO.2011.36.8456">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Han
                                  </span>
                                  <span class="cit-name-given-names">
                                   J-Y
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Park
                                  </span>
                                  <span class="cit-name-given-names">
                                   K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Kim
                                  </span>
                                  <span class="cit-name-given-names">
                                   S-W
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  First-SIGNAL: first-line single-agent iressa versus gemcitabine and cisplatin trial in never-smokers with adenocarcinoma of the lung
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Journal of Clinical Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2012
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  30
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1122
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1128
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BOncology%26rft_id%253Dinfo%253Adoi%252F10.1200%252FJCO.2011.36.8456%26rft_id%253Dinfo%253Apmid%252F22370314%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamNvIjtzOjU6InJlc2lkIjtzOjEwOiIzMC8xMC8xMTIyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMDkvMzAvMjAyMC4xMS4xMy4yMDIzMTMzMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
                                 <span>
                                  <span class="cit-reflinks-abstract">
                                   Abstract
                                  </span>
                                  <span class="cit-sep cit-reflinks-variant-name-sep">
                                   /
                                  </span>
                                  <span class="cit-reflinks-full-text">
                                   <span class="free-full-text">
                                    FREE
                                   </span>
                                   Full Text
                                  </span>
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [29].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference [29] in text" id="ref-29">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.29" data-doi="10.1016/S1470-2045(09)70364-X">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Mitsudomi
                                  </span>
                                  <span class="cit-name-given-names">
                                   T
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Morita
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Yatabe
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  The Lancet Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2010
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  11
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  121
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  128
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DThe%2Blancet%2Boncology%26rft.stitle%253DLancet%2BOncol%26rft.aulast%253DMitsudomi%26rft.auinit1%253DT.%26rft.volume%253D11%26rft.issue%253D2%26rft.spage%253D121%26rft.epage%253D128%26rft.atitle%253DGefitinib%2Bversus%2Bcisplatin%2Bplus%2Bdocetaxel%2Bin%2Bpatients%2Bwith%2Bnon-small-cell%2Blung%2Bcancer%2Bharbouring%2Bmutations%2Bof%2Bthe%2Bepidermal%2Bgrowth%2Bfactor%2Breceptor%2B%2528WJTOG3405%2529%253A%2Ban%2Bopen%2Blabel%252C%2Brandomised%2Bphase%2B3%2Btrial.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1470-2045%252809%252970364-X%26rft_id%253Dinfo%253Apmid%252F20022809%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1016/S1470-2045(09)70364-X&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=20022809&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000275152900019&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [30].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference [30] in text" id="ref-30">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.30" data-doi="10.1200/JCO.2010.33.4235">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Fukuoka
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Wu
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y-L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Thongprasert
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Biomarker analyses and final overall survival results from a phase III, randomized, open-label, first-line study of gefitinib versus carboplatin/paclitaxel in clinically selected patients with advanced non–small-cell lung cancer in Asia (IPASS)
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Journal of Clinical Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2011
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  29
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  2866
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  2874
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BOncology%26rft_id%253Dinfo%253Adoi%252F10.1200%252FJCO.2010.33.4235%26rft_id%253Dinfo%253Apmid%252F21670455%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiamNvIjtzOjU6InJlc2lkIjtzOjEwOiIyOS8yMS8yODY2IjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjIvMDkvMzAvMjAyMC4xMS4xMy4yMDIzMTMzMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink">
                                 <span>
                                  <span class="cit-reflinks-abstract">
                                   Abstract
                                  </span>
                                  <span class="cit-sep cit-reflinks-variant-name-sep">
                                   /
                                  </span>
                                  <span class="cit-reflinks-full-text">
                                   <span class="free-full-text">
                                    FREE
                                   </span>
                                   Full Text
                                  </span>
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [31].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference [31] in text" id="ref-31">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.31" data-doi="10.1056/NEJMoa0810699">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Mok
                                  </span>
                                  <span class="cit-name-given-names">
                                   TS
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Wu
                                  </span>
                                  <span class="cit-name-given-names">
                                   Y-L
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Thongprasert
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  New England Journal of Medicine
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2009
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  361
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  947
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  957
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa0810699%26rft_id%253Dinfo%253Apmid%252F19692680%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1056/NEJMoa0810699&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=19692680&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000269480400004&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [32].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference [32] in text" id="ref-32">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.32">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Inoue
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Kobayashi
                                  </span>
                                  <span class="cit-name-given-names">
                                   K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Maemondo
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Annals of Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2012
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  24
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  54
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  59
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DAnnals%2Bof%2BOncology%26rft.volume%253D24%26rft.spage%253D54%26rft_id%253Dinfo%253Apmid%252F22967997%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=22967997&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [33].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference [33] in text" id="ref-33">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.33" data-doi="10.1056/NEJMoa0909530">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Maemondo
                                  </span>
                                  <span class="cit-name-given-names">
                                   M
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Inoue
                                  </span>
                                  <span class="cit-name-given-names">
                                   A
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Kobayashi
                                  </span>
                                  <span class="cit-name-given-names">
                                   K
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Gefitinib or chemotherapy for non–small-cell lung cancer with mutated EGFR
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  New England Journal of Medicine
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2010
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  362
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  2380
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  2388
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DMaemondo%26rft.auinit1%253DM.%26rft.volume%253D362%26rft.issue%253D25%26rft.spage%253D2380%26rft.epage%253D2388%26rft.atitle%253DGefitinib%2Bor%2Bchemotherapy%2Bfor%2Bnon-small-cell%2Blung%2Bcancer%2Bwith%2Bmutated%2BEGFR.%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa0909530%26rft_id%253Dinfo%253Apmid%252F20573926%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1056/NEJMoa0909530&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=20573926&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000279043800007&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [34].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-34-1" title="View reference [34] in text" id="ref-34">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.34" data-doi="10.1002/ijc.30806">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Han
                                  </span>
                                  <span class="cit-name-given-names">
                                   B
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jin
                                  </span>
                                  <span class="cit-name-given-names">
                                   B
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Chu
                                  </span>
                                  <span class="cit-name-given-names">
                                   T
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  International Journal of Cancer
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2017
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  141
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  1249
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  1256
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DInternational%2BJournal%2Bof%2BCancer%26rft.volume%253D141%26rft.spage%253D1249%26rft_id%253Dinfo%253Adoi%252F10.1002%252Fijc.30806%26rft_id%253Dinfo%253Apmid%252F28560853%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1002/ijc.30806&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=28560853&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [35].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-35-1" title="View reference [35] in text" id="ref-35">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.35">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Yang
                                  </span>
                                  <span class="cit-name-given-names">
                                   JC-H
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Kang
                                  </span>
                                  <span class="cit-name-given-names">
                                   JH
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Mok
                                  </span>
                                  <span class="cit-name-given-names">
                                   T
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: a randomised, phase 3 trial
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  European Journal of Cancer
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2014
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  50
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  2219
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  2230
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DEuropean%2BJournal%2Bof%2BCancer%26rft.volume%253D50%26rft.spage%253D2219%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [36].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-36-1" title="View reference [36] in text" id="ref-36">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.36">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Yang
                                  </span>
                                  <span class="cit-name-given-names">
                                   JC-H
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Srimuninnimit
                                  </span>
                                  <span class="cit-name-given-names">
                                   V
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ahn
                                  </span>
                                  <span class="cit-name-given-names">
                                   M-J
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-etal">
                                  et al.
                                 </span>
                                 <span class="cit-article-title">
                                  First-Line Pemetrexed plus Cisplatin followed by Gefitinib Maintenance Therapy versus Gefitinib Monotherapy in East Asian Never-Smoker Patients with Locally Advanced or Metastatic Nonsquamous Non–Small Cell Lung Cancer: Final Overall Survival Results from a Randomized Phase 3 Study
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Journal of Thoracic Oncology
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2016
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  11
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  370
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  379
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BThoracic%2BOncology%26rft.volume%253D11%26rft.spage%253D370%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [37].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-37-1" title="View reference [37] in text" id="ref-37">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.37">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Plummer
                                  </span>
                                  <span class="cit-name-given-names">
                                   M.
                                  </span>
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  JAGS: A program for analysis of Bayesian graphical models using Gibbs sampling
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2003
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [38].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-38-1" title="View reference [38] in text" id="ref-38">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.38">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth cit-collab">
                                  R Core Team
                                 </span>
                                 .
                                 <abbr class="cit-jnl-abbrev">
                                  R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. 2013
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2014
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [39].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-39-1" title="View reference [39] in text" id="ref-39">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.39" data-doi="10.1111/1467-9868.00353">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Spiegelhalter
                                  </span>
                                  <span class="cit-name-given-names">
                                   DJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Best
                                  </span>
                                  <span class="cit-name-given-names">
                                   NG
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Carlin
                                  </span>
                                  <span class="cit-name-given-names">
                                   BP
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Van Der Linde
                                  </span>
                                  <span class="cit-name-given-names">
                                   A.
                                  </span>
                                 </span>
                                 <span class="cit-article-title">
                                  Bayesian measures of model complexity and fit
                                 </span>
                                 <abbr class="cit-jnl-abbrev">
                                  Journal of the Royal Statistical Society: Series b (Statistical Methodology)
                                 </abbr>
                                 .
                                 <span class="cit-pub-date">
                                  2002
                                 </span>
                                 ;
                                 <span class="cit-vol">
                                  64
                                 </span>
                                 :
                                 <span class="cit-fpage">
                                  583
                                 </span>
                                 –
                                 <span class="cit-lpage">
                                  639
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                                <a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bthe%2BRoyal%2BStatistical%2BSociety%253A%2BSeries%2Bb%2B%2528Statistical%2BMethodology%2529%26rft.volume%253D64%26rft.spage%253D583%26rft_id%253Dinfo%253Adoi%252F10.1111%252F1467-9868.00353%26rft_id%253Dinfo%253Apmid%252F617541238146%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url">
                                 <span>
                                  OpenUrl
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=10.1111/1467-9868.00353&link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref">
                                 <span>
                                  CrossRef
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=617541238146&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2022%2F09%2F30%2F2020.11.13.20231332.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline">
                                 <span>
                                  PubMed
                                 </span>
                                </a>
                                <a href="/lookup/external-ref?access_num=000179221100001&link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience">
                                 <span>
                                  Web of Science
                                 </span>
                                </a>
                               </div>
                              </div>
                             </li>
                             <li>
                              <span class="ref-label">
                               [40].
                              </span>
                              <a class="rev-xref-ref" href="#xref-ref-40-1" title="View reference [40] in text" id="ref-40">
                               ↵
                              </a>
                              <div class="cit ref-cit ref-journal" id="cit-2020.11.13.20231332v3.40">
                               <div class="cit-metadata">
                                <cite>
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Dias
                                  </span>
                                  <span class="cit-name-given-names">
                                   S
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Ades
                                  </span>
                                  <span class="cit-name-given-names">
                                   AE
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Welton
                                  </span>
                                  <span class="cit-name-given-names">
                                   NJ
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Jansen
                                  </span>
                                  <span class="cit-name-given-names">
                                   JP
                                  </span>
                                 </span>
                                 ,
                                 <span class="cit-auth">
                                  <span class="cit-name-surname">
                                   Sutton
                                  </span>
                                  <span class="cit-name-given-names">
                                   AJ
                                  </span>
                                 </span>
                                 .
                                 <span class="cit-article-title">
                                  Network Meta-analysis within costeffectiveness analysis
                                 </span>
                                 in
                                 <abbr class="cit-jnl-abbrev">
                                  Network meta-analysis for decision-making:155-178John Wiley & Sons, Ltd
                                 </abbr>
                                 <span class="cit-pub-date">
                                  2018
                                 </span>
                                 .
                                </cite>
                               </div>
                               <div class="cit-extra">
                               </div>
                              </div>
                             </li>
                            </ol>
                           </div>
                           <span class="highwire-journal-article-marker-end">
                           </span>
                          </div>
                          <span class="related-urls">
                          </span>
                         </div>
                        </div>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-disqus-comment">
                <div class="pane-content">
                 <div id="disqus_thread">
                  <noscript>
                   <p>
                    <a href="http://medRxiv.disqus.com/?url=https%3A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.1101%2F2020.11.13.20231332v3" class="" data-icon-position="" data-hide-link-title="0">
                     View the discussion thread.
                    </a>
                   </p>
                  </noscript>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-back-to-top">
                <div class="pane-content">
                 <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0">
                  <span class="icon-chevron-up">
                  </span>
                  Back to top
                 </a>
                </div>
               </div>
              </div>
             </div>
            </div>
            <div class="sidebar-right-wrapper grid-10 omega">
             <div class="panel-panel panel-region-sidebar-right">
              <div class="inside">
               <div class="panel-pane pane-highwire-node-pager">
                <div class="pane-content">
                 <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager">
                  <span class="pager-prev">
                   <a href="/content/10.1101/2022.09.04.22279468v3" title="The effect of alpha-cyclodextrin on postprandial glucose excursions, a systematic meta analysis Alpha-cyclodextrin and Blood Glucose" rel="prev" class="pager-link-prev link-icon">
                    <span class="icon-circle-arrow-left">
                    </span>
                    <span class="title">
                     Previous
                    </span>
                   </a>
                  </span>
                  <span class="pager-next">
                   <a href="/content/10.1101/2022.09.28.22280472v1" title="Covid-19: Qualitative Change in the Behavior of the “Virus vs Human” System - From Limit Cycle to Sustained Focus" rel="next" class="pager-link-next link-icon-right link-icon">
                    <span class="title">
                     Next
                    </span>
                    <span class="icon-circle-arrow-right">
                    </span>
                   </a>
                  </span>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-custom pane-1">
                <div class="pane-content">
                 Posted September 30, 2022.
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-panels-mini pane-biorxiv-art-tools">
                <div class="pane-content">
                 <div id="mini-panel-biorxiv_art_tools" class="highwire-2col-stacked panel-display">
                  <div class="panel-row-wrapper clearfix">
                   <div class="content-left-wrapper content-column">
                    <div class="panel-panel panel-region-content-left">
                     <div class="inside">
                      <div class="panel-pane pane-highwire-variant-link">
                       <div class="pane-content">
                        <a href="/content/10.1101/2020.11.13.20231332v3.full.pdf" target="_self" class="article-dl-pdf-link link-icon">
                         <span class="icon-external-link-sign">
                         </span>
                         <span class="title">
                          Download PDF
                         </span>
                        </a>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-highwire-variant-link">
                       <div class="pane-content">
                        <a href="/content/early/2022/09/30/2020.11.13.20231332.external-links" target="_self" class="link-icon">
                         <span class="icon-file">
                         </span>
                         <span class="title">
                          Data/Code
                         </span>
                        </a>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                   <div class="content-right-wrapper content-column">
                    <div class="panel-panel panel-region-content-right">
                     <div class="inside">
                      <div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-art-email">
                       <div class="pane-content">
                        <div class="minipanel-dialog-wrapper">
                         <div class="minipanel-dialog-link-link">
                          <a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="Email this Article" data-icon-position="" data-hide-link-title="0">
                           <i class="icon-envelope">
                           </i>
                           Email
                          </a>
                         </div>
                         <div class="minipanel-dialog-link-mini" style="display:none">
                          <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_art_email">
                           <div class="panel-panel panel-col">
                            <div>
                             <div class="panel-pane pane-block pane-forward-form pane-forward">
                              <div class="pane-content">
                               <form action="/content/10.1101/2020.11.13.20231332v3.full" method="post" id="forward-form" accept-charset="UTF-8">
                                <div>
                                 <div id="edit-instructions" class="form-item form-item-label-before form-type-item">
                                  <p>
                                   Thank you for your interest in spreading the word about medRxiv.
                                  </p>
                                  <p>
                                   NOTE: Your email address is requested solely to identify you as the sender of this article.
                                  </p>
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textfield form-item-email">
                                  <label for="edit-email">
                                   Your Email
                                   <span class="form-required" title="This field is required.">
                                    *
                                   </span>
                                  </label>
                                  <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required"/>
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textfield form-item-name">
                                  <label for="edit-name">
                                   Your Name
                                   <span class="form-required" title="This field is required.">
                                    *
                                   </span>
                                  </label>
                                  <input type="text" id="edit-name" name="name" value="" size="58" maxlength="256" class="form-text required"/>
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textarea form-item-recipients">
                                  <label for="edit-recipients">
                                   Send To
                                   <span class="form-required" title="This field is required.">
                                    *
                                   </span>
                                  </label>
                                  <div class="form-textarea-wrapper resizable">
                                   <textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea>
                                  </div>
                                  <div class="description">
                                   Enter multiple addresses on separate lines or separate them with commas.
                                  </div>
                                 </div>
                                 <div id="edit-page" class="form-item form-item-label-before form-type-item">
                                  <label for="edit-page">
                                   You are going to email the following
                                  </label>
                                  <a href="/content/10.1101/2020.11.13.20231332v3" class="active" data-icon-position="" data-hide-link-title="0">
                                   Multi-state network meta-analysis of cause-specific survival data
                                  </a>
                                 </div>
                                 <div id="edit-subject" class="form-item form-item-label-before form-type-item">
                                  <label for="edit-subject">
                                   Message Subject
                                  </label>
                                  (Your Name) has forwarded a page to you from medRxiv
                                 </div>
                                 <div id="edit-body" class="form-item form-item-label-before form-type-item">
                                  <label for="edit-body">
                                   Message Body
                                  </label>
                                  (Your Name) thought you would like to see this page from the medRxiv website.
                                 </div>
                                 <div class="form-item form-item-label-before form-type-textarea form-item-message">
                                  <label for="edit-message--2">
                                   Your Personal Message
                                  </label>
                                  <div class="form-textarea-wrapper resizable">
                                   <textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea>
                                  </div>
                                 </div>
                                 <input type="hidden" name="path" value="node/565946"/>
                                 <input type="hidden" name="path_cid" value=""/>
                                 <input type="hidden" name="forward_footer" value=" "/>
                                 <input type="hidden" name="form_build_id" value="form-vKh3e5Pj6n8V8pD8RJrFzBKykV60TO3WbKTiGsve3QA"/>
                                 <input type="hidden" name="form_id" value="forward_form"/>
                                 <fieldset class="captcha form-wrapper">
                                  <legend>
                                   <span class="fieldset-legend">
                                    CAPTCHA
                                   </span>
                                  </legend>
                                  <div class="fieldset-wrapper">
                                   <div class="fieldset-description">
                                    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
                                   </div>
                                   <input type="hidden" name="captcha_sid" value="277156078"/>
                                   <input type="hidden" name="captcha_token" value="fb8f5bbbde10616d40b57f9fd9c0272e"/>
                                   <input type="hidden" name="captcha_response" value="Google no captcha"/>
                                   <div class="g-recaptcha" data-sitekey="6LfnJVIUAAAAAE-bUOMg0MJGki4lqSvDmhJp19fN" data-theme="light" data-type="image">
                                   </div>
                                  </div>
                                 </fieldset>
                                 <div class="form-actions form-wrapper" id="edit-actions">
                                  <input type="submit" id="edit-submit" name="op" value="Send Message" class="form-submit"/>
                                 </div>
                                </div>
                               </form>
                              </div>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax" id="shareit">
                       <div class="pane-content">
                        <a href="/" class="link-icon">
                         <span class="icon-share-alt">
                         </span>
                         <span class="title">
                          Share
                         </span>
                        </a>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-panels-mini pane-biorxiv-share highwire_clipboard_form_ajax_shareit">
                       <div class="pane-content">
                        <div class="panel-display omega-12-onecol" id="mini-panel-biorxiv_share">
                         <div class="panel-panel grid-12 panel-region-preface">
                          <div class="inside">
                           <div class="panel-pane pane-highwire-article-citation">
                            <div class="pane-content">
                             <div class="highwire-article-citation highwire-citation-type-highwire-article node565946--3" data-node-nid="565946" id="node-565946--41747235413" data-pisa="medrxiv;2020.11.13.20231332v3" data-pisa-master="medrxiv;2020.11.13.20231332" data-seqnum="565946" data-apath="/medrxiv/early/2022/09/30/2020.11.13.20231332.atom">
                              <div class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix">
                               <div class="highwire-cite-title">
                                <div class="highwire-cite-title">
                                 Multi-state network meta-analysis of cause-specific survival data
                                </div>
                               </div>
                               <div class="highwire-cite-authors">
                                <span class="highwire-citation-authors">
                                 <span class="highwire-citation-author first" data-delta="0">
                                  <span class="nlm-given-names">
                                   Jeroen P.
                                  </span>
                                  <span class="nlm-surname">
                                   Jansen
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="1">
                                  <span class="nlm-given-names">
                                   Devin
                                  </span>
                                  <span class="nlm-surname">
                                   Incerti
                                  </span>
                                 </span>
                                 ,
                                 <span class="highwire-citation-author" data-delta="2">
                                  <span class="nlm-given-names">
                                   Thomas A.
                                  </span>
                                  <span class="nlm-surname">
                                   Trikalinos
                                  </span>
                                 </span>
                                </span>
                               </div>
                               <div class="highwire-cite-metadata">
                                <span class="highwire-cite-metadata-journal highwire-cite-metadata">
                                 medRxiv
                                </span>
                                <span class="highwire-cite-metadata-pages highwire-cite-metadata">
                                 2020.11.13.20231332;
                                </span>
                                <span class="highwire-cite-metadata-doi highwire-cite-metadata">
                                 <span class="doi_label">
                                  doi:
                                 </span>
                                 https://doi.org/10.1101/2020.11.13.20231332
                                </span>
                               </div>
                              </div>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                         <div class="panel-panel grid-12 panel-region-content">
                          <div class="inside">
                           <div class="panel-pane pane-highwire-article-clipboard-copy">
                            <div class="pane-content">
                             <div class="clipboard-copy">
                              <span class="label-url">
                               <label for="dynamic">
                                Share This Article:
                               </label>
                              </span>
                              <span class="input-text-url">
                               <input type="text" id="dynamic" value="https://www.medrxiv.org/content/10.1101/2020.11.13.20231332v3" size="50"/>
                              </span>
                              <span class="copy-button button">
                               <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">
                                Copy
                               </button>
                              </span>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                         <div class="panel-panel grid-12 panel-region-postscript">
                          <div class="inside">
                           <div class="panel-pane pane-service-links">
                            <div class="pane-content">
                             <div class="service-links">
                              <a href="http://digg.com/submit?phase=2&url=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&title=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo"/>
                              </a>
                              <a href="http://reddit.com/submit?url=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&title=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo"/>
                              </a>
                              <a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&text=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo"/>
                              </a>
                              <a href="http://www.facebook.com/sharer.php?u=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&t=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo"/>
                              </a>
                              <a href="http://www.google.com/bookmarks/mark?op=add&bkmk=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&title=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo"/>
                              </a>
                              <a href="http://www.linkedin.com/shareArticle?mini=true&url=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&title=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data&summary=&source=medRxiv" id="linkedin" title="Publish this post to LinkedIn" class="service-links-linkedin" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png" alt="LinkedIn logo"/>
                              </a>
                              <a href="http://www.mendeley.com/import/?url=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&title=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                               <img src="https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo"/>
                              </a>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </div>
                      <div class="panel-separator">
                      </div>
                      <div class="panel-pane pane-minipanel-dialog-link pane-biorxiv-cite-tool">
                       <div class="pane-content">
                        <div class="minipanel-dialog-wrapper">
                         <div class="minipanel-dialog-link-link">
                          <a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title="Citation Tools">
                           <span class="icon-globe">
                           </span>
                           <span class="title">
                            Citation Tools
                           </span>
                          </a>
                         </div>
                         <div class="minipanel-dialog-link-mini" style="display:none">
                          <div class="panel-display panel-1col clearfix" id="mini-panel-biorxiv_cite_tool">
                           <div class="panel-panel panel-col">
                            <div>
                             <div class="panel-pane pane-highwire-citation-export">
                              <div class="pane-content">
                               <div class="highwire-citation-export">
                                <div class="highwire-citation-info">
                                 <div class="highwire-article-citation highwire-citation-type-highwire-article cite-tool-node565946--5" data-node-nid="565946" id="citation-node-565946--6131446545" data-pisa="medrxiv;2020.11.13.20231332v3" data-pisa-master="medrxiv;2020.11.13.20231332" data-seqnum="565946" data-apath="/medrxiv/early/2022/09/30/2020.11.13.20231332.atom">
                                  <div class="highwire-cite highwire-cite-highwire-article highwire-citation-biorxiv-article-pap-list clearfix">
                                   <div class="highwire-cite-title">
                                    <div class="highwire-cite-title">
                                     Multi-state network meta-analysis of cause-specific survival data
                                    </div>
                                   </div>
                                   <div class="highwire-cite-authors">
                                    <span class="highwire-citation-authors">
                                     <span class="highwire-citation-author first" data-delta="0">
                                      <span class="nlm-given-names">
                                       Jeroen P.
                                      </span>
                                      <span class="nlm-surname">
                                       Jansen
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="1">
                                      <span class="nlm-given-names">
                                       Devin
                                      </span>
                                      <span class="nlm-surname">
                                       Incerti
                                      </span>
                                     </span>
                                     ,
                                     <span class="highwire-citation-author" data-delta="2">
                                      <span class="nlm-given-names">
                                       Thomas A.
                                      </span>
                                      <span class="nlm-surname">
                                       Trikalinos
                                      </span>
                                     </span>
                                    </span>
                                   </div>
                                   <div class="highwire-cite-metadata">
                                    <span class="highwire-cite-metadata-journal highwire-cite-metadata">
                                     medRxiv
                                    </span>
                                    <span class="highwire-cite-metadata-pages highwire-cite-metadata">
                                     2020.11.13.20231332;
                                    </span>
                                    <span class="highwire-cite-metadata-doi highwire-cite-metadata">
                                     <span class="doi_label">
                                      doi:
                                     </span>
                                     https://doi.org/10.1101/2020.11.13.20231332
                                    </span>
                                   </div>
                                  </div>
                                 </div>
                                </div>
                                <div class="highwire-citation-formats">
                                 <h2>
                                  Citation Manager Formats
                                 </h2>
                                 <div class="highwire-citation-formats-links">
                                  <span class="Z3988" title="ctx_ver=Z39.88-2004&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.spage&rft.epage&rft.atitle=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data&rft.volume&rft.issue&rft.date=2022-01-01%2000%3A00%3A00&rft.stitle&rft.jtitle=medRxiv&rft.au=Jansen%2C+Jeroen+P.&rft.au=Incerti%2C+Devin&rft.au=Trikalinos%2C+Thomas+A.">
                                  </span>
                                  <ul class="hw-citation-links inline button button-alt button-grid clearfix">
                                   <li class="bibtext first">
                                    <a href="/highwire/citation/565946/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     BibTeX
                                    </a>
                                   </li>
                                   <li class="bookends">
                                    <a href="/highwire/citation/565946/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Bookends
                                    </a>
                                   </li>
                                   <li class="easybib">
                                    <a href="/highwire/citation/565946/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     EasyBib
                                    </a>
                                   </li>
                                   <li class="endnote-tagged">
                                    <a href="/highwire/citation/565946/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     EndNote (tagged)
                                    </a>
                                   </li>
                                   <li class="endnote-8-xml">
                                    <a href="/highwire/citation/565946/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     EndNote 8 (xml)
                                    </a>
                                   </li>
                                   <li class="medlars">
                                    <a href="/highwire/citation/565946/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Medlars
                                    </a>
                                   </li>
                                   <li class="mendeley">
                                    <a href="/highwire/citation/565946/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Mendeley
                                    </a>
                                   </li>
                                   <li class="papers">
                                    <a href="/highwire/citation/565946/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Papers
                                    </a>
                                   </li>
                                   <li class="refworks-tagged">
                                    <a href="/highwire/citation/565946/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     RefWorks Tagged
                                    </a>
                                   </li>
                                   <li class="reference-manager">
                                    <a href="/highwire/citation/565946/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Ref Manager
                                    </a>
                                   </li>
                                   <li class="ris">
                                    <a href="/highwire/citation/565946/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     RIS
                                    </a>
                                   </li>
                                   <li class="zotero last">
                                    <a href="/highwire/citation/565946/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">
                                     Zotero
                                    </a>
                                   </li>
                                  </ul>
                                 </div>
                                </div>
                               </div>
                              </div>
                             </div>
                            </div>
                           </div>
                          </div>
                         </div>
                        </div>
                       </div>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-service-links">
                <div class="pane-content">
                 <div class="service-links">
                  <div class="item-list">
                   <ul>
                    <li class="first">
                     <a href="http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&count=horizontal&via=&text=Multi-state%20network%20meta-analysis%20of%20cause-specific%20survival%20data&counturl=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3" class="twitter-share-button service-links-twitter-widget" id="twitter_widget" title="Tweet This" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                      <span class="element-invisible">
                       Tweet Widget
                      </span>
                     </a>
                    </li>
                    <li>
                     <a href="http://www.facebook.com/plugins/like.php?href=https%3A//www.medrxiv.org/content/10.1101/2020.11.13.20231332v3&layout=button_count&show_faces=false&action=like&colorscheme=light&width=100&height=21&font=&locale=" id="facebook_like" title="I Like it" class="service-links-facebook-like" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                      <span class="element-invisible">
                       Facebook Like
                      </span>
                     </a>
                    </li>
                    <li class="last">
                     <a href="https://www.medrxiv.org/content/10.1101/2020.11.13.20231332v3" id="google_plus_one" title="Plus it" class="service-links-google-plus-one" rel="nofollow" data-icon-position="" data-hide-link-title="0">
                      <span class="element-invisible">
                       Google Plus One
                      </span>
                     </a>
                    </li>
                   </ul>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-highwire-article-collections">
                <h2 class="pane-title">
                 Subject Area
                </h2>
                <div class="pane-content">
                 <div class="highwire-list-wrapper highwire-article-collections">
                  <div class="highwire-list">
                   <ul class="highwire-article-collection-term-list">
                    <li class="first last odd">
                     <span class="highwire-article-collection-term">
                      <a href="/collection/health-economics" class="highlight" data-icon-position="" data-hide-link-title="0">
                       Health Economics
                       <i class="icon-caret-right">
                       </i>
                      </a>
                     </span>
                    </li>
                   </ul>
                  </div>
                 </div>
                </div>
               </div>
               <div class="panel-separator">
               </div>
               <div class="panel-pane pane-panels-mini pane-biorxiv-subject-collections block-style-col2">
                <div class="pane-content">
                 <div class="panel-flexible panels-flexible-new clearfix" id="mini-panel-biorxiv_subject_collections">
                  <div class="panel-flexible-inside panels-flexible-new-inside">
                   <div class="panels-flexible-region panels-flexible-region-new-center panels-flexible-region-first panels-flexible-region-last">
                    <div class="inside panels-flexible-region-inside panels-flexible-region-new-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
                     <div class="panel-pane pane-snippet">
                      <div class="pane-content">
                       <div class="snippet biorxiv-subject-areas-table-title" id="biorxiv-subject-areas-table-title">
                        <div class="snippet-content">
                         <b>
                          Subject Areas
                         </b>
                        </div>
                       </div>
                      </div>
                     </div>
                     <div class="panel-separator">
                     </div>
                     <div class="panel-pane pane-snippet">
                      <div class="pane-content">
                       <div class="snippet biorxiv-subject-areas-view-papers" id="biorxiv-subject-areas-view-papers">
                        <div class="snippet-content">
                         <a href="/content/early/recent">
                          <strong>
                           All Articles
                          </strong>
                         </a>
                        </div>
                       </div>
                      </div>
                     </div>
                     <div class="panel-separator">
                     </div>
                     <div class="panel-pane pane-highwire-subject-collections">
                      <div class="pane-content">
                       <ul id="collection" class="collection highwire-list-expand">
                        <li class="outer collection depth-2 child first">
                         <div class="data-wrapper">
                          <a href="/collection/addiction-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Addiction Medicine
                          </a>
                          <span class="article-count">
                           (218)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/allergy-and-immunology" class="" data-icon-position="" data-hide-link-title="0">
                           Allergy and Immunology
                          </a>
                          <span class="article-count">
                           (496)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/anesthesia" class="" data-icon-position="" data-hide-link-title="0">
                           Anesthesia
                          </a>
                          <span class="article-count">
                           (106)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/cardiovascular-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Cardiovascular Medicine
                          </a>
                          <span class="article-count">
                           (1121)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/dentistry-and-oral-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Dentistry and Oral Medicine
                          </a>
                          <span class="article-count">
                           (198)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/dermatology" class="" data-icon-position="" data-hide-link-title="0">
                           Dermatology
                          </a>
                          <span class="article-count">
                           (141)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/emergency-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Emergency Medicine
                          </a>
                          <span class="article-count">
                           (275)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease" class="" data-icon-position="" data-hide-link-title="0">
                           Endocrinology (including Diabetes Mellitus and Metabolic Disease)
                          </a>
                          <span class="article-count">
                           (510)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/epidemiology" class="" data-icon-position="" data-hide-link-title="0">
                           Epidemiology
                          </a>
                          <span class="article-count">
                           (9829)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/forensic-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Forensic Medicine
                          </a>
                          <span class="article-count">
                           (5)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/gastroenterology" class="" data-icon-position="" data-hide-link-title="0">
                           Gastroenterology
                          </a>
                          <span class="article-count">
                           (484)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/genetic-and-genomic-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Genetic and Genomic Medicine
                          </a>
                          <span class="article-count">
                           (2344)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/geriatric-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Geriatric Medicine
                          </a>
                          <span class="article-count">
                           (225)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-economics" class="" data-icon-position="" data-hide-link-title="0">
                           Health Economics
                          </a>
                          <span class="article-count">
                           (465)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-informatics" class="" data-icon-position="" data-hide-link-title="0">
                           Health Informatics
                          </a>
                          <span class="article-count">
                           (1574)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-policy" class="" data-icon-position="" data-hide-link-title="0">
                           Health Policy
                          </a>
                          <span class="article-count">
                           (738)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/health-systems-and-quality-improvement" class="" data-icon-position="" data-hide-link-title="0">
                           Health Systems and Quality Improvement
                          </a>
                          <span class="article-count">
                           (609)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/hematology" class="" data-icon-position="" data-hide-link-title="0">
                           Hematology
                          </a>
                          <span class="article-count">
                           (239)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/hiv-aids" class="" data-icon-position="" data-hide-link-title="0">
                           HIV/AIDS
                          </a>
                          <span class="article-count">
                           (510)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/infectious_diseases" class="" data-icon-position="" data-hide-link-title="0">
                           Infectious Diseases (except HIV/AIDS)
                          </a>
                          <span class="article-count">
                           (11686)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/intensive-care-and-critical-care-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Intensive Care and Critical Care Medicine
                          </a>
                          <span class="article-count">
                           (617)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/medical-education" class="" data-icon-position="" data-hide-link-title="0">
                           Medical Education
                          </a>
                          <span class="article-count">
                           (242)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/medical-ethics" class="" data-icon-position="" data-hide-link-title="0">
                           Medical Ethics
                          </a>
                          <span class="article-count">
                           (67)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/nephrology" class="" data-icon-position="" data-hide-link-title="0">
                           Nephrology
                          </a>
                          <span class="article-count">
                           (259)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/neurology" class="" data-icon-position="" data-hide-link-title="0">
                           Neurology
                          </a>
                          <span class="article-count">
                           (2170)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/nursing" class="" data-icon-position="" data-hide-link-title="0">
                           Nursing
                          </a>
                          <span class="article-count">
                           (134)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/nutrition" class="" data-icon-position="" data-hide-link-title="0">
                           Nutrition
                          </a>
                          <span class="article-count">
                           (340)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/obstetrics-and-gynecology" class="" data-icon-position="" data-hide-link-title="0">
                           Obstetrics and Gynecology
                          </a>
                          <span class="article-count">
                           (427)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/occupational-and-environmental-health" class="" data-icon-position="" data-hide-link-title="0">
                           Occupational and Environmental Health
                          </a>
                          <span class="article-count">
                           (521)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/oncology" class="" data-icon-position="" data-hide-link-title="0">
                           Oncology
                          </a>
                          <span class="article-count">
                           (1188)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/ophthalmology" class="" data-icon-position="" data-hide-link-title="0">
                           Ophthalmology
                          </a>
                          <span class="article-count">
                           (368)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/orthopedics" class="" data-icon-position="" data-hide-link-title="0">
                           Orthopedics
                          </a>
                          <span class="article-count">
                           (129)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/otolaryngology" class="" data-icon-position="" data-hide-link-title="0">
                           Otolaryngology
                          </a>
                          <span class="article-count">
                           (221)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pain-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Pain Medicine
                          </a>
                          <span class="article-count">
                           (148)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/palliative-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Palliative Medicine
                          </a>
                          <span class="article-count">
                           (50)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pathology" class="" data-icon-position="" data-hide-link-title="0">
                           Pathology
                          </a>
                          <span class="article-count">
                           (315)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pediatrics" class="" data-icon-position="" data-hide-link-title="0">
                           Pediatrics
                          </a>
                          <span class="article-count">
                           (702)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/pharmacology-and-therapeutics" class="" data-icon-position="" data-hide-link-title="0">
                           Pharmacology and Therapeutics
                          </a>
                          <span class="article-count">
                           (304)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/primary-care-research" class="" data-icon-position="" data-hide-link-title="0">
                           Primary Care Research
                          </a>
                          <span class="article-count">
                           (269)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/psychiatry-and-clinical-psychology" class="" data-icon-position="" data-hide-link-title="0">
                           Psychiatry and Clinical Psychology
                          </a>
                          <span class="article-count">
                           (2201)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/public-and-global-health" class="" data-icon-position="" data-hide-link-title="0">
                           Public and Global Health
                          </a>
                          <span class="article-count">
                           (4705)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/radiology-and-imaging" class="" data-icon-position="" data-hide-link-title="0">
                           Radiology and Imaging
                          </a>
                          <span class="article-count">
                           (786)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/rehabilitation-medicine-and-physical-therapy" class="" data-icon-position="" data-hide-link-title="0">
                           Rehabilitation Medicine and Physical Therapy
                          </a>
                          <span class="article-count">
                           (462)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/respiratory-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Respiratory Medicine
                          </a>
                          <span class="article-count">
                           (626)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/rheumatology" class="" data-icon-position="" data-hide-link-title="0">
                           Rheumatology
                          </a>
                          <span class="article-count">
                           (276)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/sexual-and-reproductive-health" class="" data-icon-position="" data-hide-link-title="0">
                           Sexual and Reproductive Health
                          </a>
                          <span class="article-count">
                           (227)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/sports-medicine" class="" data-icon-position="" data-hide-link-title="0">
                           Sports Medicine
                          </a>
                          <span class="article-count">
                           (214)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/surgery" class="" data-icon-position="" data-hide-link-title="0">
                           Surgery
                          </a>
                          <span class="article-count">
                           (254)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/toxicology" class="" data-icon-position="" data-hide-link-title="0">
                           Toxicology
                          </a>
                          <span class="article-count">
                           (43)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child">
                         <div class="data-wrapper">
                          <a href="/collection/transplantation" class="" data-icon-position="" data-hide-link-title="0">
                           Transplantation
                          </a>
                          <span class="article-count">
                           (121)
                          </span>
                         </div>
                        </li>
                        <li class="outer collection depth-2 child last">
                         <div class="data-wrapper">
                          <a href="/collection/urology" class="" data-icon-position="" data-hide-link-title="0">
                           Urology
                          </a>
                          <span class="article-count">
                           (94)
                          </span>
                         </div>
                        </li>
                       </ul>
                      </div>
                     </div>
                    </div>
                   </div>
                  </div>
                 </div>
                </div>
               </div>
              </div>
             </div>
            </div>
           </div>
          </div>
         </div>
        </div>
       </div>
      </div>
     </div>
    </div>
   </section>
  </div>
  <div class="region region-page-bottom" id="region-page-bottom">
   <div class="region-inner region-page-bottom-inner">
   </div>
  </div>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__VNH5GD8Zz7g6_hGCOZjVjdMndxxC6naiExSSJKX3k_A__kzmEdtbqCsJx5Z9yg2Qy0PptB__ufXm-TxUOl0KZzUw__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js" defer="defer">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__N7ERJBYsOWyRnJgyoM125_Aiez2MOJGaUofG1JdWWBg__2cpwCQ7-xzTVeVvg_KOzwA1jka23oWApDPpgjoZKDCY__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript" src="https://d33xdlntwy0kbs.cloudfront.net/cshl_custom_medrxiv.js">
  </script>
  <script type="text/javascript" src="https://www.medrxiv.org/sites/default/files/advagg_js/js__BmqjBnkz3MgYCAoc25s1lDRMEjLhC3mEPVonUFIHi08__Unwv5-ZIuHBfFwytsjEx1niBVJ7n1T4lPws7VrkHXM4__yDRjOTiBnSnu2tzh2xbnVTigKcZk0CFMqnf6m8vMg3M.js">
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
function euCookieComplianceLoadScripts() {}
//--&gt;&lt;!]]&gt;
  </script>
  <script type="text/javascript">
   &lt;!--//--&gt;&lt;![CDATA[//&gt;&lt;!--
var eu_cookie_compliance_cookie_name = "";
//--&gt;&lt;!]]&gt;
  </script>
 </body>
</html>
